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Abstract
Instrumental variables (IV) are extensively used to estimate treatment effects in
the presence of unmeasured confounding; however, weak IVs are often encountered
in empirical studies and may cause problems. Many studies have considered building
a stronger IV from the original, possibly weak, IV in the design stage of a matched
study at the cost of not using some of the samples in the analysis. It is widely accepted
that strengthening an IV may render nonparametric tests more powerful and typically
increases the power of sensitivity analyses. In this article, we argue that contrary to
this conventional wisdom, although a strong IV is good, strengthening an IV may
not be. We consider matched observational studies from three perspectives. First, we
evaluate the trade-off between IV strength and sample size on nonparametric tests
assuming the IV is valid and show that there are circumstances in which strengthening
an IV increases power but other circumstances in which it decreases power. Second,
we derive a necessary condition for a valid sensitivity analysis model with continuous
doses. We show that the Γ sensitivity analysis model, which has been previously used
to come to the conclusion that strengthening an IV makes studies less sensitive to
bias, does not apply to the continuous IV setting and thus this previously reached
conclusion may be invalid. Third, we quantify the bias of the Wald estimator with
a possibly invalid IV under an oracle called the asymptotic oracle bias and leverage
it to develop a valid sensitivity analysis framework; under this framework, we show
that strengthening an IV may amplify or mitigate the bias of the estimator, and may
or may not increase the power of sensitivity analyses. We also discuss how to better
adjust for the observed covariates when building an IV.
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1 Introduction
1.1 Instrumental variable methods in causal inference with a matching design
An instrumental variable (IV) can be thought of as a haphazard encouragement to take
some treatment whose only effect on the outcome is through its effect on the treatment. A
randomized encouragement design is an ideal prototype (Holland, 1988). In a randomized
encouragement design, if the encouragement is associated with the treatment, affects the
outcome only through the treatment, and is independent of unobserved confounders, the
encouragement is said to be a valid IV. A valid IV can be used to obtain bounds on the
average treatment effect (Balke and Pearl, 1997) and, under additional assumptions, to
obtain a consistent estimate of the average treatment effect (for a certain subpopulation or
the whole population depending on the assumptions) (Holland, 1988; Angrist et al., 1996;
Hernán and Robins, 2006). This “randomized encouragement” perspective of an IV can
be further combined with matching, a nonparametric technique of adjusting for observed
covariates, when the IV is believed to be randomized conditional on a set of observed
covariates. In a matched observational study, subjects with similar observed covariates are
put in the same matched set, and comparisons are made within these matched sets (Rubin,
1973; Rosenbaum, 2002, 2010; Hansen, 2004; Rubin, 2008; Stuart, 2010; Zubizarreta, 2012;
Pimentel et al., 2015). This study design approach to IV has at least three nice features.
First, it facilitates blinding like in a randomized trial as the study is designed before looking
at the outcomes. Second, it facilitates nonparametric, randomization inference under the
assumption that the IV is valid, and associated sensitivity analysis to examine how sensitive
a conclusion is to a putative IV being invalid. Third, it provides a unified framework to
deal with continuous and binary outcomes; see Baiocchi et al. (2012) for a more detailed
introduction.
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An example of this matching design approach to IV analysis concerns the following: does
delivery of a preterm infant at a high-level neonatal intensive care unit (NICU) compared
to a low-level NICU increase infants’ length of hospital stay? A high-level NICU is one with
a high level of technology, particularly resuscitative capacity, and high volume, whereas a
low-level NICU lacks at least one of these features (Lorch et al., 2012). Following Baiocchi
et al. (2010), we consider data on all premature births in Pennsylvania from 1995 to 2004
plus the first six months of 2005. The putative IV leveraged in the study is the excess
travel time, defined as the travel time (in minutes) to the nearest high-level NICU minus
the time to the nearest low-level NICU. Such an excess distance IV has been widely used
in health studies, e.g., McClellan et al. (1994).
Excess travel time would be a valid IV if a mother’s risk of having a long length of stay
(e.g., due to complications of the birth or the baby experiencing problems) is not related
to whether the mother lives close to a high-level NICU. However, high-level NICUs tend to
be in urban areas and mothers living in urban areas are on average different than mothers
living in rural areas in ways that might be related to the mother’s risk of a long length of
stay. To control for confounders of the relationship between living near a high-level NICU
and length of stay, we follow Baiocchi et al. (2010) and use optimal non-bipartite matching
(Lu et al., 2011) to pair mothers with similar observed covariates X, including variables
related to mother’s pregnancy and socioeconomic status, but different excess travel times.
After matching, each matched pair consists of one mother who lives “near” to a high-level
NICU (i.e., excess travel time smaller) and another mother who lives “far” from a high-level
NICU (i.e., excess travel time larger). The first three columns of Table 1 summarizes the
covariate balance of matched pairs in the “near group” and the “far group” of the study.
See Supplementary Materials A.1 for details on how the statistical matching is performed.
After matching, the covariates are well-balanced with standardized differences near zero.
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One can apply permutation-based inferential methods to the matched samples and estimate
the treatment effects (Baiocchi et al., 2010). This matching-based study design approach
to building an IV is also referred to as “near/far matching” (Baiocchi et al., 2012). Notable
empirical studies that use near/far matching include Lorch et al. (2012), Goyal et al. (2013),
Neuman et al. (2014), Santana-Davila et al. (2015), Berkowitz et al. (2017, 2019), Lum et al.
(2017), and Grieve et al. (2019).
1.2 Strength of IVs and problems with weak IVs
While encouragement creates incentives for subjects to accept the treatment, some may
fail to comply with this encouragement. An encouragement is said to be a strong IV if it
is strongly associated with the treatment and weak if it is only weakly associated (Bound
et al., 1995). When the IV is binary, the strength of the IV is measured by the compliance
rate, defined to be the proportion of individuals who would accept treatment if encouraged
but would not accept treatment if not encouraged (Imbens and Rosenbaum, 2005).
It is well recognized that studies using weak IVs face several problems. With weak
IVs, the usual two-stage least squares (2SLS) estimation method leads to invalid inference
(Staiger and Stock, 1994; Bound et al., 1995; Stock et al., 2002). This problem can be fixed
by using a permutation-based method of inference. Second, even valid, permutation-based
inference suffers from low finite sample power and excessively long and non-informative
confidence intervals (Imbens and Rosenbaum, 2005). This problem can be fixed by increas-
ing the sample size. A third, and perhaps more worrisome, problem is that weak IVs are
invariably sensitive to small or moderate biases, no matter the sample size (Staiger and
Stock, 1994; Small and Rosenbaum, 2008; Ertefaie et al., 2018). With a weak IV, even a
small correlation between the IV and the unmeasured confounder greatly increases the bias
of IV estimators (Bound et al., 1995; Small and Rosenbaum, 2008). Moreover, the power of
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a sensitivity analysis, defined as the probability that a study rejects a false null hypothesis
when a specified magnitude of unobserved bias in the IV is allowed for (Rosenbaum, 2004,
2005), drastically decreases for a weak IV even if it is only slightly biased; see Small and
Rosenbaum (2008) and Ertefaie et al. (2018) for a detailed account.
1.3 A strong IV is good, but strengthening an IV may not be
Weak IVs can be problematic; a strong IV, when available, is preferable. In many practical
situations, however, strong IVs are not available. To overcome this conundrum, many works
have proposed to strengthen an existing, possibly weak, IV in the design stage of matched
observational studies (Baiocchi et al., 2010; Zubizarreta et al., 2013; Ratkovic and Shiraito,
2014; Yang et al., 2014; Keele et al., 2016, 2018; Lehmann et al., 2017; Ertefaie et al., 2018;
Fogarty et al., 2019).
Intuitively, ceteris paribus, a larger dose of encouragement creates stronger incentives
for subjects to accept treatment (e.g., living nearer to a high-level NICU creates a stronger
incentive to attend a high-level NICU). One strategy that exploits this intuition builds
a stronger IV from an existing one by making average matched pair differences in the
IV larger, at the cost of throwing away some of the samples; see Baiocchi et al. (2010),
Zubizarreta et al. (2013), Yang et al. (2014), Keele et al. (2016, 2018), Ertefaie et al. (2018)
and Fogarty et al. (2019). We followed Baiocchi et al. (2010) and built a stronger IV by
only forming half as many matched pairs as the data allows. The last three columns of
Table 1 summarize the covariate balance of this strengthened IV.
We will demonstrate there is a fundamental difference between a naturally strong IV and
building a stronger IV. We have four objectives in this article. First, we would like to clarify
the potential outcome framework and the related randomization-based inferential proce-
dures in matching design approaches to IV analysis with continuous IVs. Second, we exhibit
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when strengthening a valid IV improves the finite sample power of some popular nonpara-
metric test statistics, and when it does not. Third, we discuss what constitutes a valid
randomization-based sensitivity analysis to examine the potential bias due to an invalid
IV. A surprising consequence of our discussion is that the widely used Γ sensitivity analysis
model, sometimes called Rosenbaum bounds, cannot be directly applied in the continuous
IV setting. We show that, contrary to previously reported conclusions that strengthening
an IV increases the power of sensitivity analyses in large samples, strengthening an IV
may or may not increase the power of a sensitivity analysis under our framework and we
illuminate the factors which determine whether it increases the power of a sensitivity anal-
ysis. R code necessary to reproduce the main results in this article is available via https:
//github.com/siyuheng/Code-for-IV-to-Strengthen-or-not-to-Strengthen-.
2 Review: IV methods in pair matched studies
2.1 The potential outcome framework and IV assumptions for a binary IV
We first consider a setting with a binary IV. An example of a study with a binary IV is
Bronars and Grogger (1994) who, in a study of the effect of out-of-wedlock fertility on
labor supply, used whether an unwed mother’s first birth was to a singleton baby vs. twins
(mothers who gave birth to triplets or more were not considered). Suppose there are I
matched pairs, each consisting of 2 individuals. For a study with a binary IV, individual
j (j = 1, 2) in matched pair i (i = 1, . . . , I) is associated with a binary IV (i.e., an
encouragement) Zij, a vector of observed covariates xij, an unmeasured confounder uij, a
binary treatment indicatorDij, and an outcome of interestRij. Let Z = (Z11, . . . , ZI2), D =
(D11, . . . , DI2) and R = (R11, . . . , RI2) denote the vectors of encouragement assignments,
treatments, and outcomes for 2I subjects. Let Z be the collection of all encouragement
indicator vectors Z such that Zi1 + Zi2 = 1 for all i.
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We consider the potential outcome framework (Neyman, 1923; Rubin, 1974) for the
IV setting as in Angrist et al. (1996). Let Dij(Z) be the indicator for whether subject ij
would receive the treatment or not if the encouragement assignment vector is set to Z, and
Rij(Z,D) the outcome of ij if the encouragement assignment vector is Z and the treatment
assignment vector is D. We assume the stable unit treatment value assumption (SUTVA): if
Zij = Z
′
ij, then Dij(Z) = Dij(Z′); if Zij = Z ′ij and Dij = D′ij, then Rij(Z,D) = Rij(Z′,D′).
SUTVA says that encouragement affects only the subject being encouraged (no interference
among units) and there are no different versions of the encouragement. In addition to
SUTVA, we assume that the exclusion restriction holds: Rij(Z,D) = Rij(Z′,D) for all
Z,Z′ and D. Under SUTVA and the exclusion restriction, the following counterfactuals
are well defined: dT ij is the treatment subject ij would have if encouraged, dCij is the
treatment the subject would have if not encouraged, rT ij is the outcome the subject would
have if encouraged, and rCij is the outcome the subject would have if not encouraged. The
observed treatment Dij and observed outcome Rij satisfy Dij = ZijdT ij + (1−Zij)dCij and
Rij = ZijrT ij + (1 − Zij)rCij. Write F = {(xij, uij, dT ij, dCij, rT ij, rCij) : i = 1, . . . , I, j =
1, 2}.
In addition to SUTVA and exclusion restriction, there are three more assumptions
commonly used in a randomized encouragement design: (1). Random Assignment: P (Zi1 =
1 | F ,Z) = P (Zi2 = 1 | F ,Z) = 1/2 for all i, possibly conditional on xi1 = xi2; (2).
Positive Correlation (Between IV and Treatment): E(D | Z = 1,X = x) > E(D | Z =
0,X = x) for all x; (3). Monotonicity: dT ij ≥ dCij for all i, j. The random assignment can
be satisfied if the IV is physically randomly assigned as in a randomized encouragement
study or if it is independent of unmeasured confounders conditional on the covariates X (so
effectively randomly assigned). In an IV analysis, a subject belongs to one of the following
four classes: 1) an always-taker if (dT ij, dCij) = (1, 1); 2) a complier if (dT ij, dCij) = (1, 0);
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3) a never-taker if (dT ij, dCij) = (0, 0); 4) a defier if (dT ij, dCij) = (0, 1). The monotonicity
assumption excludes defiers. For a detailed discussion of these assumptions, see Angrist
et al. (1996) and Baiocchi et al. (2014). An IV that satisfies the assumptions (i.e., SUTVA,
the exclusion restriction, random assignment, and positive correlation) is called a valid IV;
otherwise, it is invalid.
2.2 Randomization inference with a binary IV in paired studies
In a randomization inference for a randomized encouragement design, the only probabil-
ity distribution that enters the inference is the distribution of encouragement assignments
that describes the encouragement assignment mechanism; potential outcomes under en-
couragement or control are held fixed (Fisher, 1935; Imbens and Rosenbaum, 2005). A
randomization-based inferential procedure can be conducted by looking at the probability
that a test statistic T is greater than or equal to the observed value t:
P (T ≥ t | F ,Z) =
∑
z∈Z
1(T (z,R) ≥ t) · P (Z = z | F ,Z) = |z ∈ Z : T (z,R) ≥ t||Z| ,
where T is a statistic that tests a null hypothesis concerning the counterfactuals (dT ij, dCij,
rT ij, rCij), and P (Z = z | F ,Z) = 1/|Z| = 1/2I for all z ∈ Z with a valid binary IV.
Small and Rosenbaum (2008) considered testing the null hypothesis H0 : β = β0 in the
following model:
rT ij − rCij = β(dT ij − dCij). (1)
Model (1) is called the proportional treatment effect because the effect of the encouragement
on the outcome is proportional to its effect on the treatment. Under model (1), we have
rT ij − βdT ij = rCij − βdCij ∆= ij. Let Yi = (Zi1 − Zi2)(Ri1 − Ri2) and Si = (Zi1 −
Zi2)(Di1 − Di2). We have Yi − βSi = (Zi1 − Zi2)(i1 − i2) ∆= i. Under the random
assignment of encouragements assumption, i takes on value |i1 − i2| or −|i1 − i2| with
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equal probability 1/2, and in order to test H0 : β = β0, it suffices to test whether Yi−β0Si =
i + (β − β0)Si is symmetrically distributed about zero, which can be done, for instance,
by applying the Wilcoxon signed rank test or the sign test to Yi − β0Si (Lehmann, 2004).
Randomization-based inferential procedures could also use the randomization distribution
of a combined quantile average (Rosenbaum, 1999) or the sample mean of Yi−β0Si (Imbens
and Rosenbaum, 2005), yielding a Wald estimator (Wald, 1940), or equivalently two-stage
least squares,
β̂IV =
Ê[ Rij | Zij = 1 ]− Ê[ Rij | Zij = 0 ]
Ê[ Dij | Zij = 1 ]− Ê[ Dij | Zij = 0 ]
=
∑I
i=1(Zi1 − Zi2)(Ri1 −Ri2)∑I
i=1(Zi1 − Zi2)(Di1 −Di2)
.
More recently, Baiocchi et al. (2010) developed a randomization-based inferential procedure
for IV analysis that allows for heterogeneous treatment effects in paired studies, and Kang
et al. (2016) further generalized it to the case of full matching, allowing for matching with
different numbers of controls across matched strata.
2.3 Near/far matching: embedding continuous IVs into pair matched studies
The NICU study described in Section 1 involves a continuous IV, excess travel time. We
clarify how to adapt the randomization-based IV analysis for binary IVs to the setting
of continuous IVs using a matching design approach in this section. A matching design
approach to IV analysis (e.g., near/far matching) typically pairs subjects with similar
observed covariates X, but different continuous IVs Z˜. For instance, in the NICU study,
two mothers with similar socioeconomic and health status, but different excess travel times
to the nearest high-level NICU are paired together. In each matched pair i, a binary
encouragement indicator Zij is constructed out of Z˜ij: Zi1 = 1 (encouraged) and Zi2 = 0
(not encouraged, i.e., control) if Z˜i1 < Z˜i2 and vice versa. In the NICU study, the continuous
IV Z˜ is the excess travel time to the nearest high-level NICU, and the individual with a
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smaller Z˜ in each matched pair is seen as being encouraged to deliver at a hospital with a
high-level NICU and assigned Z = 1.
To develop a valid randomization-based inference, one needs to carefully define the
encouragement being manipulated/randomized and the fixed potential outcomes under
encouragement/control. In their original paper that leveraged excess travel time as an IV
to study high-level NICU’s effect on neonatal death, Baiocchi et al. (2010) asked:
What would have happened to a mother and her newborn had she lived either
close to or far from a high-level NICU? Here there are two responses, (rT ij, rCij)
or (dT ij, dCij), where rT ij and dTij are observed from the j-th subject in pair i
under [encouragement], Zij = 1, whereas rCij and dCij are observed from the
j-th subject in pair i under control [no encouragement], Zij = 0.
This notion of encouragement and control has been adopted in many subsequent works
(Baiocchi et al., 2010; Zubizarreta et al., 2013; Keele et al., 2016, 2018; Lehmann et al.,
2017; Ertefaie et al., 2018; Fogarty et al., 2019). One way to interpret this statement is the
following: for each subject ij, the encouragement that may be manipulated/randomized is
the binary encouragement indicator Zij = 1, corresponding to the subject living close to
a high-level NICU, and Zij = 0, corresponding to the subject living far from a high-level
NICU. However, the potential outcomes (rT ij, rCij) are not fixed under this definition of
encouragement and control. For example, say mother ij is paired to a mother who has an
excess travel time of 30 minutes. Consider whether mother ij has an excess travel time
of 5 or 15 minutes. In either case, mother ij will be the encouraged mother in the pair.
Mother ij might be willing to travel 5 more minutes to go to a high-level NICU but not 15
more minutes. Say mother ij would have a longer length of stay if she went to a high-level
NICU than a low-level NICU. Then SUTVA (Rubin, 1980) is violated because there are
versions of the encouragement which lead to different potential outcomes.
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To have well-defined potential outcomes and SUTVA hold, the encouragement (control)
assignment in a pair needs to define an exact dose of the IV that is received, e.g., exact
excess travel time in the NICU study. This can be achieved by considering a randomized
encouragement assignment in which in pair i, if the excess travel times are Z˜i1, Z˜i2, a fair
coin is flipped and if the coin lands heads, subject i1 is assigned IV Z˜i1 and subject i2 is
assigned IV Z˜i2 and vice versa if the coin lands tails. Let Z˜ = (Z˜11. . . . , Z˜I2) be the dose
assignment (i.e., the continuous IV) vector, Dij(Z˜) the indicator for whether subject ij
receives the treatment or not given Z˜, and Rij(Z˜,D) the outcome of subject ij under Z˜
and D. Similar to the binary IV case, SUTVA and the exclusion restriction (Holland, 1988;
Rosenbaum, 1989) state that: (1). Z˜ij = Z˜ ′ij implies Dij(Z˜) = Dij(Z˜′), and Z˜ij = Z˜ ′ij and
Dij = D
′
ij together imply Rij(Z˜,D) = Rij(Z˜′,D′); (2). Rij(Z˜,D) = Rij(Z˜′,D) for all Z˜, Z˜′
and D. Let Z˜∨ = (Z˜11∨Z˜12, Z˜21∨Z˜22, . . . , Z˜I1∨Z˜I2) and Z˜∧ = (Z˜11∧Z˜12, Z˜21∧Z˜22, . . . , Z˜I1∧
Z˜I2), where a∨ b = max(a, b) and a∧ b = min(a, b), represent the maximum and minimum
of two doses in each matched pair. Under SUTVA and the exclusion restriction, potential
outcomes (dT ij, dCij, rT ij, rCij) are well-defined and fixed after matching:
dT ij
∆
= (Dij | Z˜ij = Z˜ij ∧ Z˜ij′), dCij ∆= (Dij | Z˜ij = Z˜ij ∨ Z˜ij′),
rT ij
∆
= (Rij | Z˜ij = Z˜ij ∧ Z˜ij′), rCij ∆= (Rij | Z˜ij = Z˜ij ∨ Z˜ij′),
(2)
for j 6= j′. That is, instead of defining the potential outcomes of subject ij with re-
spect to whether Zij = 1(Z˜ij < Z˜ij′) = 1 or 0, which violates SUTVA as discussed
above, we define potential outcomes with respect to the continuous dose. Write F =
{(xij, uij, dT ij, dCij, rT ij, rCij) : i = 1, . . . , I, j = 1, 2}, where dT ij, dCij, rT ij, rCij are defined
as in (2). In a randomization inference with the continuous IV Z˜, the only probability distri-
bution that enters statistical inference is the conditional probability P (Z˜i1 = Z˜i1∧Z˜i2, Z˜i2 =
Z˜i1∨ Z˜i2 | F , Z˜∨, Z˜∧) that characterizes the underlying dose assignment mechanism in each
matched pair i. By conditioning on Z˜∨ and Z˜∧, we only know the maximum and mini-
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mum of (Z˜i1, Z˜i2) for each i, but not which individual takes on which value. When Z˜ is
a valid IV that is physically randomized as in a randomized encouragement design, then
this dose assignment mechanism is created by the experimenter and known to us: P (Z˜i1 =
Z˜i1∧Z˜i2, Z˜i2 = Z˜i1∨Z˜i2 | F , Z˜∨, Z˜∧) = P (Z˜i1 = Z˜i1∨Z˜i2, Z˜i2 = Z˜i1∧Z˜i2 | F , Z˜∨, Z˜∧) = 1/2,
and forms the “reasoned basis for inference” in Fisher’s phrase. When there are unmeasured
confounders of the IV-outcome relationship as is typical in an observational study, the dose
assignment mechanism for the IV may deviate from randomization, and some parsimonious
model is often imposed to describe this biased dose assignment mechanism. We analyze the
trade-off between sample size and strength in the context of randomization-based inference
with a valid IV in Section 3, and explore in detail what constitutes a valid dose assignment
model in the presence of unmeasured confounding in Section 4.
3 Strengthening a valid IV: IV strength versus sample size
Small and Rosenbaum (2008) leveraged a matching design approach to reanalyze a study
by Angrist and Krueger (1994) concerning the effects of military services during World War
II on subsequent earnings, in which people from different birth cohorts who are otherwise
similar are “encouraged” or “discouraged” to serve in the military depending on when they
turned 18, e.g., people who turned 18 in 1944 were more encouraged than people who turned
18 in 1946. By selecting people from different birth cohorts, IVs of different strength and
with unequal sample sizes can be created. Such a trade-off between IV strength and sample
size also naturally emerges when part of the sample is discarded in order to forge a stronger
IV in the design stage of matched observational studies. Given valid IVs of different sample
sizes and distinct strength, which should one prefer in the context of nonparametric testing
in matched studies?
11
3.1 Quantitative evaluation of the trade-off between IV strength and sample size
We consider testing the null hypothesis H0 : β = β0 in model (1), the proportional treat-
ment effect model, in a matched pair study using the Wilcoxon signed rank test or the sign
test as introduced in Section 2. Recall that the error term i = Yi − βSi takes on value
|i1 − i2| or −|i1 − i2| with equal probability. We assume that i, i = 1, ..., I are i.i.d.
realizations from a distribution F where F is symmetric about zero given that the IV is
valid. Following Ertefaie et al. (2018), we consider a model that says an individual is an
always-taker with probability ιA, a complier with probability ιC (i.e., the compliance rate),
and a never-taker with probability ιN . We have ιA + ιN + ιC = 1 as there are no defiers
under the monotonicity assumption. Denote the mean of rCij for compliers to be µC , for
always-takers µA, and for never-takers µN . We assume that the compliance categories of
different individuals are independent, and the distribution of rCij for always-takers and
that for never-takers are both location shifts from that of compliers. Let I be the num-
ber of matched pairs. We now derive the asymptotic relative efficiency (ARE) of testing
H0 : β = β0 in model (1) when there are two valid IVs of different strength.
Theorem 1 (Quantitative trade-off between IV strength and sample size). Consider a
sequence of testing problems consisting of a null hypothesis H0 : β = β0 versus H1 = βn.
Suppose that βn = β0+∆/
√
n+o(1/
√
n) and without loss of generality, suppose that ∆ > 0.
Let piI(·) be the power function of the one-sided Wilcoxon signed rank test (or the sign test)
when testing the proportional treatment effect model in a randomized encouragement design
using I matched pairs. Let In be the minimum number of matched pairs needed such that
piIn(β0) ≤ α and piIn(βn) ≥ γ for some α ∈ (0, 1) and γ ∈ (α, 1). Let In,1 and In,2 be the
number of matched pairs needed for two given sequences of tests using two different valid
IVs: one with parameters %1 = (ιC,1, ιA,1, ιN,1, µC,1, µA,1, µN,1) and the other with parameters
%2 = (ιC,2, ιA,2, ιN,2, µC,2, µA,2, µN,2). Suppose that the compliance structure (dT ij, dCij) is
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independent of rCij for both IVs, implying that µC,1 = µA,1 = µN,1 and µC,2 = µA,2 = µN,2.
Let f(x) be the density function of the error term i. Suppose that f is continuously
differentiable, lim
x→∞
f(x) = 0, and f ∈ L2. For both the Wilcoxon signed rank test and the
sign test, we have
lim
n→∞
In,1
In,2
=
ι2c,2
ι2c,1
.
Proofs of all theorems in this paper are in Supplementary Materials B.
For a more general version of Theorem 1 where the compliance structure (dT ij, dCij)
can be correlated with rCij for both IVs, see Theorem 5 in Supplementary Materials B.1.
Theorem 1 helps explain some empirical findings in the literature. For instance, Small
and Rosenbaum (2008) found the 95% confidence interval obtained from inverting the
Wilcoxon signed rank test based on 14, 000 pairs of veterans born in the 1926−1928 cohort
is [−1, 445,−500], which is much shorter than that based on 28, 000 pairs of veteran born
in the 1924−1928 cohort. This result is not surprising in light of Theorem 1, because birth
time is a much stronger “encouragement” for the 1926-1928 cohort to participate in the
Vietnam War compared to the 1924-1928 cohort (estimated compliance rate 0.51 versus
0.27 and 0.512/0.272 >> 28, 000/14, 000). Theorem 1 also resonates with similar results
in the two-stage least squares (2SLS) literature. The variance of the 2SLS estimator is at
least as large as the variance from having a sample of N × ι2C (N the total sample size)
known compliers, and the standard error, or the length of the confidence interval, at least
scales proportional to
√
N × ιC (Imbens and Angrist, 1994; Baiocchi et al., 2014).
3.2 Simulations
We assess how accurately the asymptotic result in Theorem 1 captures this trade-off in finite
samples via simulations. For a fixed IV strength ιC , fixed proportions of always-takers and
never-takers, and a fixed α level, we use Monte Carlo simulations to determine the sample
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size needed to achieve a specified power γ when the effect size is β−β0 = 0.1. We use binary
search to search for the sample size and 20, 000 simulated datasets to estimate the power
for each sample size. Specifically, we consider three different pairs of IV: a pair of IVs that
are slightly different in strength with (ιC,1 = 0.5, ιC,2 = 0.6), a pair moderately different
with (ιC,1 = 0.4, ιC,2 = 0.7), and a pair vastly different with (ιC,1 = 0.3, ιC,2 = 0.8). Table 2
summarizes the sample size ratio determined via simulation, and contrasts it to the ARE
when the error is normal or Laplace, and the level is set to be 0.05. We see simulation
results agree very well with ARE, with relative error less than 1%, and the sample size
ratio is independent of nuisance parameters ιA, ιN , and error distribution. Figure 1a, 1b,
and 1c plot power against sample size for three pairs of IVs when the error is normal, and
1d plots the ratio of sample sizes needed for the stronger and weaker IVs in each pair to
attain the same power. The ratio of sample size agrees perfectly with the theoretical value
ι2C,2/ι
2
C,1 (three background lines in Figure 1d) for all cases. Similar plots when the error is
Laplace can be found in Supplementary Materials C.1.
4 What constitutes a valid sensitivity analysis with continuous IVs?
When an IV is effectively randomized, then when asking whether we should strengthen
it, the key question is how the power compares before and after the IV is strengthened;
this was the question we considered in Section 3. In observational studies, however, it
is often unrealistic to assume the encouragement is effectively randomized, even after a
set of observed covariates are controlled for. A sensitivity analysis asks how a departure
from random assignment of encouragement would affect the causal conclusion drawn from
a primary analysis that assumes the encouragement is effectively randomized. In this
section, we review the Γ sensitivity analysis model developed for a binary IV, and discuss
what constitutes a valid model for describing the biased dose assignment mechanism when
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IVs are continuous. A rather surprising consequence of our result is that, despite being used
extensively in the literature (Baiocchi et al., 2010; Zubizarreta et al., 2013; Keele et al.,
2016; Lehmann et al., 2017; Ertefaie et al., 2018; Fogarty et al., 2019), the Γ sensitivity
analysis model is not a valid model for biased dose assignment mechanism when IVs are
continuous.
4.1 Review: the Γ sensitivity analysis model for a binary IV
In a randomized encouragement experiment with a binary encouragement, we have P (Z =
z | F ,Z) = 1/|Z| = 1/2I for all z ∈ Z. The model of Rosenbaum (2002, Chapter 4)
quantifies the potential departure from randomization using one parameter Γ ≥ 1 and has
been extensively used in the causal inference literature as a sensitivity analysis framework.
Let piij = P (Zij = 1 | F) denote the probability that individual j in matched pair i receives
the encouragement. Two individuals ij and ij′ in the same matched pair i, i.e., xij = xij′ ,
may differ in their chances of receiving the encouragement by at most a factor of Γ ≥ 1:
1
Γ
≤ piij(1− piij′)
piij′(1− piij) ≤ Γ, for all i, j, j
′ with xij = xij′ . (3)
When the encouragement Z is randomized in each pair, then Γ = 1. The more Γ devi-
ates from 1, the more encouragement assignment potentially deviates from randomization.
Model (3) is equivalent to the following treatment assignment model (assuming xij = xij′)
with γ = log(Γ) ≥ 0:
P (Z = z | F ,Z) =
I∏
i=1
exp(γ
∑2
j=1 zijuij)∑2
j=1 exp(γuij)
, z ∈ Z, 0 ≤ uij ≤ 1, (4)
where uij ∈ [0, 1] is an unmeasured confounder not matched upon for individual ij; see
Rosenbaum (2002) for more details. Under the null hypothesis H0 and model (3), or
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equivalently under model (4), the permutation distribution of the test statistic becomes
P (T ≥ t | F ,Z) =
∑
z∈Z
1(T (z,R) ≥ t) ·
I∏
i=1
exp(γ
∑2
j=1 zijuij)∑2
j=1 exp(γuij)
.
For different values of Γ, a sensitivity analysis gives the corresponding range of all possible
p-values and confidence intervals. In a sensitivity analysis for a one-sided test with Γ =
exp(γ), researchers are interested in the “worst-case” p-value reported by a test statistic T
given its observed value t:
max
0≤uij≤1
P (T ≥ t | F ,Z) = max
0≤uij≤1
∑
z∈Z
1(T (z,R) ≥ t) ·
I∏
i=1
exp(γ
∑2
j=1 zijuij)∑2
j=1 exp(γuij)
.
In practice, an empirical researcher gradually increases the sensitivity parameter Γ, com-
putes the worst-case p-value for each Γ, and reports the largest Γ such that this worst-case
p-value exceeds some prespecified level α. Such a changepoint Γ is known as the sensitivity
value (Zhao, 2019) and informs the audience of the magnitude of potential hidden bias
needed to alter the causal conclusion. Rosenbaum (1989) showed that for a large class of
nonparametric test statistics, in a pair matched study, the worst-case p-value is obtained
when the subject with higher response in each matched pair has an unmeasured confounder
u = 1 and the other has u = 0.
4.2 A necessary condition for a valid sensitivity analysis model
When the IVs are continuous, for a randomization inference, one should condition on the
minimum and maximum doses in a pair as we argued in Section 2.3. Using the notation
introduced in Section 2.3, the dose assignment mechanism is the conditional probability
P (Z˜i1 = Z˜i1∧ Z˜i2, Z˜i2 = Z˜i1∨ Z˜i2 | F , Z˜∨, Z˜∧), which reduces to a constant 1/2 with a valid
IV and otherwise does not. When there is unmeasured confounding, some parsimonious
model is often prescribed to describe this biased dose assignment mechanism. For example,
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Baiocchi et al. (2010) proposed to model it using the Γ sensitivity analysis model reviewed
in Section 4.1, which was adopted by many subsequent works mentioned above.
A valid sensitivity analysis model for describing the biased dose assignment mechanism
in each matched pair should correspond to a valid data generating process in the population
prior to matching. Theorem 2 states that such a valid sensitivity analysis model must
incorporate the information about the minimum and maximum continuous doses in a pair.
A surprising consequence of Theorem 2 is that the Γ sensitivity analysis model, which does
not incorporate continuous doses, is not valid in the continuous IV setting.
Theorem 2 (An exclusion principle). Let Z˜ be a continuous IV, X a vector of observed
covariates, and U a hypothesized unmeasured confounder. Denote the conditional density
function f(Z˜ = z˜ | X = x, U = u) as ξ(z˜,x, u), with (z˜,x, u) ∈ Rp+2 where p is the
dimension of X. Let G denote the collection of all nonnegative functions g(z˜,x, u) such that
g(z˜,x, u) = η(x, u)ζ(z˜,x)ϑ(z˜, u) for some nonnegative functions η, ζ, and ϑ, where ϑ is a
function that has continuous second partial derivatives over the support of g. If ξ(z˜,x, u) ∈
G, then the following two statements (S1) and (S2) cannot hold true simultaneously: (S1)
Z˜ is an invalid IV conditional on X, i.e., Z˜ 6⊥ U | X; (S2) The dose assignment probability
in each matched pair i, i.e., P (Z˜i1 = Z˜i1∧ Z˜i2, Z˜i2 = Z˜i1∨ Z˜i2 | F , Z˜∨, Z˜∧), does not depend
on (Z˜i1 ∧ Z˜i2, Z˜i1 ∨ Z˜i2).
Remark 1. Note that G contains models that describe dose assignment mechanisms in
the population, not in each pair after matching. G covers a large class of dose assignment
models in the literature, with and without unmeasured confounding. For example, the
class of all dose assignment models for a valid continuous IV, i.e., f(Z˜ = z˜ | X = x), is
a subclass of G and corresponds to taking η(x, u) = 1, ζ(z˜,x) = f(Z˜ = z˜ | X = x), and
ϑ(z˜, u) = 1. The partially linear model Z˜ = h(X) +γ ·U +  where U has an additive effect
on Z˜ and  is normally distributed belongs to G. The semiparametric model considered in
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Rosenbaum (1989) also belongs to G with ϑ(z˜, u) = exp(γ · z˜u) for some constant γ. See
Supplementary Materials A.2 for more details.
Theorem 2 is proved in Supplementary Materials B.3 and we only give some intu-
ition here. Suppose that (S2) is true and f(Z˜ = z˜ | X = x, U = u) factors into
η(x, u)ζ(z˜,x)ϑ(z˜, u) for some functions η, ζ, and ϑ, where ϑ is smooth. It can be shown
that ∂2 lnϑ(z˜, u)/∂z˜∂u ≡ 0, which implies that ϑ(z˜, u) is separable, i.e., there exist ϑ1
and ϑ2 such that ϑ(z˜, u) = ϑ1(z˜)ϑ2(u). Therefore, f(Z˜ = z˜ | X = x, U = u) =
η(x, u)ζ(z˜,x)ϑ1(z˜)ϑ2(u) ∝ ζ(z˜,x)ϑ1(z˜), which implies that Z˜ |= U | X and thus (S1) cannot
possibly hold. Note that the Γ sensitivity analysis model does not incorporate the infor-
mation of doses (Z˜i1 ∧ Z˜i2, Z˜i1 ∨ Z˜i2), and therefore does not constitute a valid sensitivity
analysis model when the IV is continuous according to Theorem 2. We further illustrate
this point using the NICU data in Supplementary Materials A.3.
Previous theoretical development for a strengthened IV in the presence of unmeasured
confounding has assumed the Γ sensitivity analysis model. Conclusions drawn under this
model, e.g., strengthening an IV increases the power of a sensitivity analysis, may no
longer apply when IVs are continuous in light of previous discussion. In the next section,
we quantify the bias in inference from a biased continuous IV and use it to develop a valid
sensitivity analysis framework in the following section, and then use this framework to
reevaluate previous conclusions about strengthening IVs.
5 Assessing an IV estimator via asymptotic oracle bias (AOB)
When the IV is valid and the monotonicity assumption holds, Angrist et al. (1996) showed
that the Wald estimator, which coincides with two stage least squares when the treatment
and IV are binary, nonparametrically estimates the average treatment effect among com-
pliers (CATE): E{rT − rC | (dT , dC) = (1, 0)}. Recall the Wald estimator in a matched
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study is:
β̂IV =
Ê[ Rij | Zij = 1 ]− Ê[ Rij | Zij = 0 ]
Ê[ Dij | Zij = 1 ]− Ê[ Dij | Zij = 0 ]
=
∑I
i=1(Zi1 − Zi2)(Ri1 −Ri2)∑I
i=1(Zi1 − Zi2)(Di1 −Di2)
, (5)
where Zi1 = 1(Z˜i1 < Z˜i2) and Zi2 = 1(Z˜i1 > Z˜i2) assuming no ties of Z˜ in each matched
pair. We let ι̂C = (1/I)
∑I
i=1(Zi1 − Zi2)(Di1 −Di2) denote the average encouraged-minus-
control difference in the treatment indicator D. Note that ι̂C consistently estimates the
compliance rate under the random assignment assumption (Angrist et al., 1996). Following
Ertefaie et al. (2018), we will refer to ι̂C as the estimated compliance rate below.
Our new framework evaluates the bias of the Wald estimator and serves as the basis
for a new sensitivity analysis framework to be discussed in Section 7. Our framework is
distinct from previous frameworks in that we incorporate the information contained in the
original continuous IV Z˜. We first clarify some concepts, notation and assumptions. A
matching algorithm M acting on N samples can be viewed as a mapping MN from the
information of N individuals F˜ = {qn = (Z˜n,Xn, Un) : n = 1, . . . , N} to a partition ΠI
that divides 2I matched individuals into I matched pairs {{qi1, qi2} : i = 1, . . . , I}. A valid
matching algorithm involves only the information of covariates Xn and continuous scores
Z˜n. Definition 1 formalizes this statement.
Definition 1 (A valid matching algorithmM). A matching algorithmM is said to be valid
if the output of M (i.e., matched sets) is determined only by the information of observed
covariates and IVs.
Conditional on {Xn, n = 1, ..., N} and {Z˜n, n = 1, ..., N}, a valid matching algorithm
M is independent of the unmeasured confounders U = (U1, . . . , UN), i.e.,
M |= U | {(Xn, Z˜n) : n = 1, . . . , N}.
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Matching algorithms applied to continuous IVs that satisfy Definition 1 include Baiocchi
et al. (2010), Zubizarreta et al. (2013), Yang et al. (2014), Keele et al. (2016, 2018), Ertefaie
et al. (2018), and Fogarty et al. (2019).
We evaluate the bias of the Wald estimator under the following partially linear model
for the outcome R:
Rn = βDn + f(Xn) + δUn + n, n = 1, . . . , N, (6)
where Xn are observed covariates, f(Xn) an arbitrary function of Xn, and Dn the treat-
ment indicator. Un represents the aggregate impact of possibly more than one unmea-
sured confounders (variables that have effects on the response and are not independent of
the treatment given the observed covariates), and n represent i.i.d. random factors with
E[n] = 0, Var[n] = σ2, and {n : n = 1, . . . , N} |= {(Z˜n,Xn, Un) : n = 1, . . . , N} so that
n are not confounders. Similar representations of unmeasured confounding can also be
found in Imbens (2003) and Imai et al. (2010). In practice, the treatment effect could be
heterogeneous (Angrist et al., 1996), and the Wald estimate does not rely on the homoge-
neous treatment effect assumption. To illuminate the main issues involved in strengthening
IVs, we will focus on the bias of the Wald estimator under model (6). We call this the
oracle bias where oracle refers to evaluating the bias under the oracle knowledge of model
(6) holding. Theorem 3 gives the asymptotic normality of β̂IV, which will be leveraged to
develop a valid sensitivity analysis framework in Section 7.
Theorem 3 (Asymptotic normality of the Wald estimator with possibly invalid IVs).
Suppose the outcome satisfies model (6), and a valid matching algorithm M is applied to
N samples and yields I matched pairs. As N → ∞ and consequently I → ∞, the Wald
estimator β̂IV satisfies
β̂IV − β − Bias(β̂IV)
sd(β̂IV)
L−→ N (0, 1),
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where sd(β̂IV) =
√
2σ·[√I ·̂ιC ]−1 and Bias(β̂IV) =
∑I
i=1(Zi1−Zi2)[f(Xi1)−f(Xi2)]∑I
i=1(Zi1−Zi2)(Di1−Di2)
+δ·
∑I
i=1(Zi1−Zi2)(Ui1−Ui2)∑I
i=1(Zi1−Zi2)(Di1−Di2)
.
The oracle bias of β̂IV is a finite-sample quantity. If we further assume that data are
realizations from some superpopulation model, we can derive the asymptotic oracle bias
(AOB) of β̂IV under regularity conditions. The AOB formula yields more insights into
when strengthening an IV reduces the bias and when not.
Suppose that each qn = (Z˜n,Xn, Un), n = 1, . . . , N , is an i.i.d. realization from a
distribution G. For the encouraged individual in matched pair i, i.e., the one with the
smaller Z˜ in pair i, the associated information vector qT i = (Z˜T i,XT i, UT i) follows the
marginal distribution GMN ,T induced by G and the matching algorithm M applied to
{qn, n = 1, . . . , N}. Analogously, the information vector qCi = (Z˜Ci,XCi, UCi) associated
with each control in pair i, i.e., the individual with the larger Z˜ in pair i, follows a marginal
distribution GMN ,C . To stress, GMN ,T and GMN ,C depend on G, the matching algorithm
M, and sample size N . Assumption 1 says GMN ,T and GMN ,C have well-defined limits as
N →∞, and Assumption 2 requires convergence in probability of some sample quantities.
Assumption 1 (Convergence of the distribution of matched samples). As N → ∞ and
consequently I →∞, we have GMN ,T L−→ GM,T and GMN ,C L−→ GM,C for some distributions
GM,T and GM,C.
Assumption 2 (Convergence of sample means of matched data). Let EM,T [·] and EM,C [·]
denote the expectations under distributions GM,T and GM,C. As N →∞ and correspond-
ingly I →∞, we have 1
I
∑I
i=1 DT i
p−→ EM,T [D]; 1I
∑I
i=1DCi
p−→ EM,C [D]; 1I
∑I
i=1 f(XT i)
p−→
EM,T [f(X)]; 1I
∑I
i=1 f(XCi)
p−→ EM,C [f(X)]; 1I
∑I
i=1 UT i
p−→ EM,T [U ] and 1I
∑I
i=1 UCi
p−→
EM,C [U ].
Theorem 4 derives the AOB of β̂IV.
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Theorem 4 (The asymptotic oracle bias of the Wald estimator). Suppose the outcome
satisfies model (6). A valid matching algorithm M is applied to N samples and yields I
matched pairs. Suppose Assumptions 1 and 2 hold. As N →∞ and consequently I →∞,
the Wald estimator β̂IV satisfies:
β̂IV − β p−→ EM,T [f(X)]− EM,C [f(X)]EM,T [D]− EM,C [D] + δ ·
EM,T [U ]− EM,C [U ]
EM,T [D]− EM,C [D] , (7)
where EM,T [·] and EM,C [·] denote the expectations under distributions GM,T and GM,C.
6 Comparing IV designs: two sources of bias
Consider expression (7) which gives the asymptotic bias of the Wald estimator. The bias
is decomposed into two components: a bias due to the residual imbalance of X after
matching, which is captured by the term (EM,T [f(X)]−EM,C [f(X)])/(EM,T [D]−EM,C [D]),
and a bias due to failing to adjust for U , which is captured by the term (EM,T [U ] −
EM,C [U ])/(EM,T [D]−EM,C [D]). We now leverage expression (7) to compare two designs.
6.1 Bias due to residual imbalance after matching
In practice, exact matching on the observed covariates may not be attainable and there
will be residual imbalance due to not perfectly matching/balancing the observed covariates.
Suppose we are now in a favorable situation where there is no unmeasured confounder, i.e.,
δ = 0. The AOB of the Wald estimator then reduces to
AOB(β̂IV) =
EM,T [f(X)]− EM,C [f(X)]
EM,T [D]− EM,C [D] . (8)
Let M0 be a matching algorithm that constructs an IV, M1 a strengthening-IV al-
gorithm that constructs a stronger IV, and β̂IV,M0 and β̂IV,M1 be the Wald estimators
computed fromM0 andM1, respectively. Consider a linear model f(X) = XTγ for some
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γ = (γ1, . . . , γp)
T . Suppose there are p observed covariates, {X1, X2, ..., Xp}, all of which,
except possibly Xp, are well-balanced for both matching algorithmsM0 andM1. By “Xi
is well-balanced”, we mean the marginal means of Xi in the “near group” and “far group”
are approximately equal. This information can be easily read off from the balance table
(e.g., Table 1).
Magnitudes of biases due to not well balancing the observed covariate Xp for designs
M0 andM1, under this linear f(·), are
|AOB(β̂IV,f(·),M0)| =
∣∣∣∣γp · EM0,T [Xp]− EM0,C [Xp]EM0,T [D]− EM0,C [D]
∣∣∣∣ (9)
and
|AOB(β̂IV,f(·),M1)| =
∣∣∣∣γp · EM1,T [Xp]− EM1,C [Xp]EM1,T [D]− EM1,C [D]
∣∣∣∣ , (10)
respectively. Expressions (9) and (10) suggest that in this simple scenario, if the marginal
mean of Xp is well-balanced in the “near group” and “far group” for both designs, the
strengthening-IV algorithmM1 would largely reduce this bias through increasing the com-
pliance (the denominator). On the other hand, if the balance ofXp significantly deteriorates
after the IV is strengthened, both the numerator |EM,T [Xp] − EM,C [Xp]| and the denom-
inator |EM,T [D] − EM,C [D]| would grow larger inM1 compared toM0, and it is unclear
whether the magnitude of bias due to not perfectly balancing Xp becomes larger or smaller.
In practice, f(·) is not linear and many covariates are not exactly matched. Without
knowing the actual functional form f(·), little definite can be said. The biases due to
not perfectly matching on X1, . . . , Xp may add up and be very large or they may happen
to cancel each other. However, it is meaningful that practitioners keep in mind that the
strengthening-IV algorithm may introduce bias into the Wald estimator as a by-product of
inferior balance on observed covariates. One useful strategy is to make sure that covariate
balance after strengthening is no worse than that in the original design. In Supplemen-
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tary Materials A.7, we discuss how to incorporate this objective into existing matching
algorithms and illustrate the approach using a subset of the NICU study data.
6.2 Bias due to the unmeasured confounder
When exact or near-exact matching on the observed covariates X is possible, the conditional
distributions of X in the encouragement group (“near” group) and the control group (“far”
group) are the same and the magnitude of the AOBs for the two designs reduces to
|AOB(β̂IV,M0)| =
∣∣∣∣δ · EM0,T [U ]− EM0,C [U ]EM0,T [D]− EM0,C [D]
∣∣∣∣ and |AOB(β̂IV,M1)| = ∣∣∣∣δ · EM1,T [U ]− EM1,C [U ]EM1,T [D]− EM1,C [D]
∣∣∣∣ .
The ratio of the magnitude of bias due to unmeasured confounding is
∆ =
|AOB(β̂IV,M1)|
|AOB(β̂IV,M0)|
=
∣∣∣∣EM0,T [D]− EM0,C [D]EM1,T [D]− EM1,C [D]
∣∣∣∣× ∣∣∣∣EM1,T [U ]− EM1,C [U ]EM0,T [U ]− EM0,C [U ]
∣∣∣∣ . (11)
The first factor in expression (11) is the ratio of encouraged-minus-control difference of
the treatment indicator D after matching using algorithmsM0 andM1, while the second
factor captures the ratio of average encouraged-minus-control difference in the unmeasured
confounder U after matching. Whether or not the magnitude of bias contributed by U
increases depends on both ratios. Strengthening an IV makes the first ratio in (11) less
than 1 but may make the second ratio in (11) greater than 1. Example 1 highlights this
point using the NICU data, and a simulation is provided in Supplementary Materials C.2
for further illustration.
Example 1 (Bias of the Wald estimator in NICU data). Consider a hypothetical NICU
dataset where, contrary to the fact, the single birth indicator is not collected. The analyst
would not know this and the best he or she could do is to match on all observed covariates.
We therefore match on all covariates except the single birth indicator and examine the
bias due to this unmeasured confounder in the near/far matching algorithm (M0) without
24
strengthening the IV and the strengthening-IV algorithm (M1) that only forms half as
many matched pairs as the data allows. The estimated compliance rate is 0.21 inM0 and
0.42 in M1. The average encouraged-minus-control differences in the unmatched single
birth indicator are 1.89×10−3 for designM0 and 5.01×10−3 for designM1. Put together,
the magnitude of bias evaluates to δ × 9.16 × 10−3 for design M0 and δ × 1.19 × 10−2
for M1, and hence the ratio of bias is ∆ = 1.30 > 1. In this hypothetical scenario, M1
amplifies the bias of the Wald estimator due to the unmeasured confounder (i.e., the single
birth indicator).
7 A valid AOB-based model-assisted sensitivity analysis framework
Suppose that we have controlled for all observed covariates available in a study via match-
ing, what can be said about an IV design’s sensitivity to unmeasured confounding? We
answer this question by developing a valid model-assisted sensitivity analysis.
7.1 A general sensitivity analysis framework
A sensitivity analysis outputs a range of plausible values of the parameter of interest, when
an assumption is allowed to be violated up to a certain magnitude. Consider the data
generating process (6) described in Section 5. Our goal is to output a range of plausible
values of β when unmeasured confounding is present (i.e., δ 6= 0). Below, we derive and
describe a unified sensitivity analysis framework based on the AOB formula. There are
three key ingredients in our framework.
(1) A parametric model that relates U to Z˜ and X: To still make inference on β
in the presence of unmeasured confounding, we need to quantify the bias due to it. Recall
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the AOB of β̂IV (conditional on Xi1 = Xi2) is
AOB(β̂IV) = δ · EM,T [U ]− EM,C [U ]EM,T [D]− EM,C [D] ,
where the denominator can be directly estimated from data and the numerator involves
expectations of U in the encouragement group and the control group. The following key
observation helps estimate these two expectations:
EM,T [U ]− EM,C [U ] = EM,T{EM,T [U | Z˜,X]} − EM,C{EM,C [U | Z˜,X]}
Definition 1
======== EM,T{E[U | Z˜,X]} − EM,C{E[U | Z˜,X]},
(12)
where E[U | Z˜,X] refers to the expectation of U given Z˜ and X prior to matching in
the population. Equation (12) suggests that in order to estimate the bias contributed by
U , it suffices to posit a model for U | Z˜,X before matching, provided that the matching
algorithmM is valid (Definition 1) and thus independent of U .
(2) A sensitivity zone: Consider a parametric or possibly semiparametric model of
U | Z˜,X parametrized by some finite-dimensional parameter θ. Given modeling assump-
tions on U | Z˜,X, we may identify θ from the observed data. However, the identification is
typically very weak and these parameters would better be regarded as sensitivity parame-
ters (Copas and Li, 1997; Scharfstein et al., 1999; Imbens, 2003). A sensitivity zone refers
to a set of plausible values of sensitivity parameters and is denoted as I. The simplest
form of a sensitivity zone is the Cartesian product of intervals or general point sets of each
coordinate of θ and the scalar δ. In many situations, however, it helps to reparametrize the
sensitivity parameters from θ to parameters that are easier to understand and communicate
(Imbens, 2003; Rosenbaum and Silber, 2009; Cinelli and Hazlett, 2019).
(3) A sensitivity interval: The output of our sensitivity analysis is a 100(1 − α)%
finite-sample sensitivity interval (SI) of β given a sensitivity zone I, which contains the
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true β with probability at least 1−α for any unknown true sensitivity parameter (δ,θ) ∈ I.
In Supplementary Materials A.5, we described in detail how to construct a 100(1 − α)%
confidence interval of β given the true (δ,θ) by treating {(Ui1, Ui2), i = 1, ..., I} as missing
covariates and adopting the multiple imputation (MI) paradigm (Rubin, 1987; Ichino et al.,
2008). For each fixed (δ,θ) ∈ I, a 100(1− α)% confidence interval of β is
CI(δ,θ) =
[
K−1
K∑
k=1
β̂IV,k − t−1ν (1− α/2) · σ̂total, K−1
K∑
k=1
β̂IV,k + t
−1
ν (1− α/2) · σ̂total
]
,
where there are K imputed data sets,
β̂IV,k = β̂IV − δ ·
∑I
i=1(Zi1 − Zi2)(U (k)i1 − U (k)i2 )∑I
i=1(Zi1 − Zi2)(Di1 −Di2)
, k = 1, . . . , K,
with {(U (k)i1 , U (k)i2 ), i = 1, ..., I} being the k-th imputed set of U according to the speci-
fied model for U | Z˜,X given the sensitivity parameter (δ,θ), and K−1∑Kk=1 β̂IV,k is the
pooled estimate for β under (δ,θ). The estimated total variance of the pooled estimate
K−1
∑K
k=1 β̂IV,k is
σ̂2total =
1 +K−1
K − 1
K∑
k=1
(
β̂IV,k −K−1
K∑
k=1
β̂IV,k
)2
+K−1
K∑
k=1
2σ̂2k
I · ι̂2C
, (13)
and t−1ν is the quantile function of the Student’s t-distribution with degrees of freedom
ν = (K − 1)
[
1 +
K−1
∑K
k=1 2σ̂
2
k · [I · ι̂2C ]−1
1+K−1
K−1
∑K
k=1
(
β̂IV,k −K−1
∑K
k=1 β̂IV,k
)2
]2
.
A 100(1 − α)% sensitivity interval (SI) of β given the sensitivity zone I is then SI =⋃
(δ,θ)∈I CI(δ,θ).
In expression (13), σ̂2k is an estimate of σ2 based on the k-th imputed data set. One
estimation strategy is to posit a model for f(Xn) in (6); in Supplementary Materials A.6,
27
we show that σ2 can also be estimated from matched pair data without positing a model
for f(Xn), but some other additional models, including a model relating D, X, U and
Z˜. The additional model(s) make the sensitivity analysis model-assisted. The primary
analysis, the Wald estimator after matching (i.e., the β̂IV defined in (5)), is nonparametric.
Model-assisted sensitivity analyses that complement primary analyses have been proposed
in other contexts (Imbens, 2003; Rosenbaum and Silber, 2009; Nattino and Lu, 2018).
7.2 An example of AOB-based model-assisted sensitivity analysis
We illustrate the proposed AOB-based model-assisted sensitivity analysis framework by
describing a concrete model for U | Z˜,X and associated parametrization of sensitivity
parameters. Consider the following simple and parsimonious model:
Z˜ ∼ H(·), such that EZ˜∼H(·)[Z˜] = 0 and VarZ˜∼H(·)[Z˜] = 1,
U ∼ Bern
(
exp(λ0 + λ1Z˜)
1 + exp(λ0 + λ1Z˜)
)
.
(14)
According to model (14), there exists a binary unmeasured confounder in the population,
and Z˜ has mean zero and unit variance in the population, marginally. To incorporate
observed covariates X, we specify that model (14) holds when Z˜ is replaced with
≈
Z =
(Z˜ −E[Z˜ | X])/σ(Z˜ | X), the standardized residual of Z˜ after the effect of X is taken out.
In practice, we may fit a linear regression of Z˜ on X, take the residual, and scale it to
have mean 0 and variance 1. It facilitates interpretation to reparametrize the sensitivity
parameters (λ0, λ1) into (τ, λ1), where τ = P (U = 1 | Z˜ > Median(Z˜)) − P (U = 1 | Z˜ <
Median(Z˜)). In this way, τ quantifies how important U is to Z˜ conditional on Z˜ being either
some constant c above or below the median of Z˜, and λ1 quantifies how fast P (U = 1 |
Z˜ = Median(Z˜) + c) changes as c changes for c > 0. One nuance in this reparametrization
is that the map from (λ0, λ1) to (τ, λ1) is not surjective: there are combinations of (τ, λ1)
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that do not correspond to any choice of (λ0, λ1). After this reparametrization, there are a
total of three sensitivity parameters in this sensitivity analysis model: (δ, τ, λ1). Let ∆ be
a collection of plausible values for δ, and similarly T for τ and Λ for λ1. For the sensitivity
zone, we consider I(∆,T ,Λ) = ∆× T ×Λ.
7.3 Comparing IV designs via the power of sensitivity analyses
When the treatment indeed has an effect on the outcome of interest, we would not be
able to recognize this from observational data and if a large enough amount of unmeasured
confounding is considered, a sensitivity analysis will say the observed treatment effect might
be purely due to this unmeasured confounding rather than a genuine treatment effect. The
situation where there is a genuine treatment effect and no unmeasured confounding is called
a favorable situation (Heller et al., 2009; Rosenbaum, 2010). In such a favorable situation,
we would like a sensitivity analysis to conclude that the treatment effect is insensitive to a
small or moderately large amount of unmeasured confounding. The power of a sensitivity
analysis is the probability that we are able to make such a statement when unmeasured
confounding is limited up to some extent (Rosenbaum, 2004, 2010).
We examine power in our model-assisted sensitivity analysis framework in this section.
We consider the sensitivity analysis discussed in Section 7.2. Let (Rn, Dn, Z˜n, X1n, X2n,
X3n), n = 1, . . . , 1000, be i.i.d. data generated from the following model:
Z˜n
i.i.d.∼ N (0, 1), Dn ∼ Bern
(
exp(ξZ˜n)
1 + exp(ξZ˜n)
)
, (X1n, X2n, X3n) ∼ N (0, I3), n i.i.d.∼ N (0, 1),
Rn = β ·Dn + 0.2 ·X1n + 0.5 · log(|X2n|) + 0.3 · sin(X3n) + n, (15)
where Z˜ is a continuous IV, D a binary treatment, (X1, X2, X3) three observed covariates,
and R an observed outcome. We conducted a sensitivity analysis under model (14) with
reparametrized sensitivity parameters (τ, λ1, δ).
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We calculate the finite sample power of this sensitivity analysis under the favorable
situation (15) for two designs: an “unstrengthened” IV design M0 that uses all data and
forms 500 matched pairs with similar (X1, X2, X3) but distinct Z˜, and a “strengthened” IV
design M1 that only forms half as many matched pairs as the data allows (250 matched
pairs) where the pairs are still similar in (X1, X2, X3) but are even more distinct in Z˜;
see Supplementary Materials A.1 for details on matching. For each simulated dataset and
a fixed sensitivity zone I = {τ} × {λ1} × [−δsup, δsup], we calculate the 95% sensitivity
interval SI =
⋃
(δ,θ)∈I CI(δ,θ) as described in Section 7.1, and reject the null hypothesis of
no treatment effect (i.e., β = 0 in the hypothesized outcome model (6)) if the SI does not
contain the origin (to focus on main issues in illuminating the effect of strengthening the IV,
we assume the true σ = 1 is known). Table 3 summarizes the results for various sensitivity
zones (indexed by (δsup, λ1) with τ = 0.01) and different data generating processes of D
(indexed by ξ). The estimated compliance rate ι̂C , average bias, and average standard
deviation for both designs are also reported in the table.
Table 3 suggests that under our framework, the strengthening-IV design sometimes but
does not always increase the power of a sensitivity analysis. Whether or not strengthening-
IV designs would increase or decrease the power of a sensitivity analysis depends on how
strengthening affects both bias and variance. When the sampling variability is small com-
pared to the bias (e.g., when the sample size I is very large or the association between
the unmeasured confounder and the outcome δ is very large), the power is primarily de-
termined by the bias of the Wald estimator. If a strengthening-IV design M1 amplifies
the bias compared to a unstrengthening-IV design M0, we would expect M1 to have a
smaller power of sensitivity analysis; ifM1 mitigates the bias compared toM0, we would
expect M1 to have a larger power. See Section 6.2 for a detailed discussion on when a
strengthening-IV design would amplify or mitigate the bias. Table 3 exhibits cases (with
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β = 4 and δsup = 10) where the standard deviation of the estimate is small compared to the
bias (e.g., SD = 0.27 and Bias = 3.21 forM0 when ξ = 4.0 and λ1 = 6.0), and the power
is driven by the bias. For instance, when ξ = 4.0 and 5.0, we see that the strengthening-IV
designM1 amplifies the bias compared toM0, and as a result it decreases the power of a
sensitivity analysis. Our observation and conclusion here is distinct from previous results
derived from the Γ sensitivity analysis model: Ertefaie et al. (2018) showed that, in a favor-
able situation, testing using a strong IV (e.g., a “strengthened” IV) always exhibits a larger
insensitivity to unmeasured confounding asymptotically (known as the design sensitivity),
compared to doing the same test but with a weaker IV.
When the biases of both designs are comparable, the variance of the estimator con-
tributes significantly to the power. Table 3 exhibits cases (with β = 0.8 and δsup = 0.5)
where the biases of both designs are about the same but the standard deviations are quite
different (e.g., when ξ = 1.0 and λ1 = 1.0, the estimated biases under both designs are
0.14; the standard deviation is 0.27 forM0 and 0.22 forM1). In such cases, a design with
smaller sampling variability often exhibits a larger power (e.g.,M1 is more powerful than
M0 when ξ = 1.0 and λ1 = 1.0).
7.4 Sensitivity analysis for the NICU study
We apply the proposed sensitivity analysis model to the NICU data described in Section 1.
The outcome of interest is infants’ length of stay at hospital. For infants who died, we
imputed the 99% upper quantile of survivors length of stay; this is a burden of illness
approach to analyzing the length of stay in which death is considered to be a very bad
outcome (Chang et al., 1994; Lin et al., 2017). The 95% confidence interval of the naive
Wald estimator assuming no unmeasured confounding is [0.78, 1.90] for a near/far matching
designM0 that does not strengthen the IV, and [1.04, 1.80] for the strengthening-IV design
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M1. Thus, if the IV of excess travel time is valid, we have evidence that high-level NICUs
increase infants’ length of stay at a hospital.
We next consider doing a sensitivity analysis under model (14). For each (τ, λ1, δ)
combination, we estimate σ assuming f(Xn) in (6) is linear in Xn, and construct the
sensitivity interval according to the MI paradigm discussed in Section 7.1. For each (τ, λ1)
combination, Figure 2a reports the largest ∆ (denoted as ∆sup), where ∆ is defined as δ
divided by the standard deviation of the outcome, such that the 95% sensitivity interval
does not contain 0 for designM0, and Figure 2b plots the same information for designM1.
In both figures, darker shades correspond to larger ∆sup, i.e., a larger association between
the outcome and the hypothesized unmeasured confounder needed in order to nullify the
conclusion that high-level NICUs increase length of stay for both designs.
For either design, we consider a sensitivity zone of τ from 0.01 to 0.04 and λ1 from 1 to
3. A λ1 as large as 3 means that for one standard deviation increase in
≈
Z, the standardized
residual of Z˜, we expect to see an exp(3) ≈ 20-fold increase in the odds of U = 1 versus
U = 0. On the other hand, τ encodes the difference in P (U = 1) conditional on
≈
Z being
above or below its median. To get a sense of how large τ could be, we may look at the
value of τ if U were an observed covariate. This value equals 0.01 for the covariate “single
birth” and 0.06 for the covariate “white”. The combination τ ×λ1 = [0.01, 0.04]× [1, 3] thus
encodes a wide range of possible relationships between U and Z˜, and Figure 2 suggests that
it would require a moderate to enormous association between the unmeasured confounder
and the outcome in order to nullify the causal conclusion for both designs.
As we compare Figure 2a to 2b, we observe that the strengthened IV does not always
exhibit larger insensitivity: there are (τ ×λ1) combinations such thatM0 exhibits a larger
insensitivity (darker shade) and vice versa. Recall that small λ1 means that P (U = 1 | Z˜ =
Median(Z˜) + c) does not change rapidly as c changes, which corresponds to the strength of
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unmeasured confounding not being much modified by the continuous IV Z˜. Therefore, not
surprisingly, when λ1 is small, we observe the strengthened IV seems to be more robust to
unmeasured confounding compared to the unstrengthened IV.
8 Discussion: the implications and some practical advice
In this article, we study the implications of building a stronger IV from an existing, but
possibly weak, IV in the design stage of a matched analysis. We spell out the potential out-
come framework in a matching design approach to continuous IV analysis, and clarify what
constitutes a valid sensitivity analysis model for randomization-based inference in this set-
ting. In particular, we demonstrate, via extensive theory and real data examples, that the
extensively used Γ sensitivity analysis framework is in general not valid in the continuous
IV setting. This observation implies theoretical analyses based on the Γ sensitivity analysis
framework that are valid in a binary IV setting, for instance conclusions concerning the
power of a sensitivity analysis, may not extend to the continuous IV setting. We developed
a new framework to assess IV designs’ sensitivity to unmeasured confounding based on
evaluating the bias of the Wald estimator. Indeed, under our framework, strengthening an
IV may not increase the power of sensitivity analyses.
We now provide some practical guidance for empirical researchers based on our results.
When an IV is believed to be valid conditional on the set of observed covariates, efficiency
of testing is an important criterion. Our first set of results quantifies the relative efficiency
of performing hypothesis testing using IVs of different strength: in order for a weaker IV
(with compliance rate ιc,1) to attain the same power as a stronger IV (with compliance
rate ιc,2 such that ιc,2 > ιc,1), the weaker IV needs to have a sample size that is at least
(ι2c,2/ι
2
c,1) times the sample size of the stronger IV. If an empirical researcher has multiple
binary IVs, he or she may build a stronger IV by defining one aggregate binary IV out of
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them. For instance, one may define encouragement to be “doubly encouraged” or “multiply
encouraged”, meaning a person is encouraged if two or more IVs simultaneously prod her
into accepting the IV. A valid and potentially stronger IV with smaller sample size will
be forged, and our theory provides some insight into when this is a good idea. As for a
continuous IV, one can always forge a stronger IV using the strategy illustrated in Baiocchi
et al. (2010), i.e. optimal non-bipartite matching with sinks. Our result suggests that
practitioners may throw away as much as three-fourths of the sample if they believe doing so
may double the compliance rate, or half of the data if doing so may increase the compliance
rate by roughly 40%.
When there is a concern about the validity of the putative IV, i.e., there is unmeasured
confounding, we found that strengthening an IV in the design stage may amplify or miti-
gate the bias of the Wald estimator due to not controlling for the unmeasured confounding.
A strengthening-IV design is favorable if it helps reduce the bias due to unmeasured con-
founding. In practice, we do not get to observe the unmeasured confounder. One sensible
strategy is to sequentially leave out each observed covariate and calculate how omitting
the covariate affects the bias as in Example 1. One might pay particular attention to the
results from leaving out observed covariates that are thought to be related to unmeasured
confounders of greatest concern. There is also bias due to inexact matching in reality.
Strengthening an IV, valid or not, may potentially amplify this bias. We recommend that
empirical researchers make sure that covariate balance is no worse in the strengthening-IV
design compared to the original design, which can be achieved in some circumstances via
a two-step matching algorithm described in our Supplementary Materials A.7.
Acknowledgement
The authors would like to thank José Zubizarreta for helpful discussions and Michael
Baiocchi for sharing the code for the NICU study.
34
References
Angrist, J. and Krueger, A. B. (1994). Why do world war ii veterans earn more than
nonveterans? Journal of labor economics, 12(1):74–97.
Angrist, J. D., Imbens, G. W., and Rubin, D. B. (1996). Identification of causal effects using
instrumental variables. Journal of the American Statistical Association, 91(434):444–455.
Baiocchi, M., Cheng, J., and Small, D. S. (2014). Instrumental variable methods for causal
inference. Statistics in Medicine, 33(13):2297–2340.
Baiocchi, M., Small, D. S., Lorch, S., and Rosenbaum, P. R. (2010). Building a stronger
instrument in an observational study of perinatal care for premature infants. Journal of
the American Statistical Association, 105(492):1285–1296.
Baiocchi, M., Small, D. S., Yang, L., Polsky, D., and Groeneveld, P. W. (2012). Near/far
matching: a study design approach to instrumental variables. Health Services and Out-
comes Research Methodology, 12(4):237–253.
Balke, A. and Pearl, J. (1997). Bounds on treatment effects from studies with imperfect
compliance. Journal of the American Statistical Association, 92(439):1171–1176.
Berkowitz, S. A., Seligman, H. K., Rigdon, J., Meigs, J. B., and Basu, S. (2017). Supple-
mental nutrition assistance program (snap) participation and health care expenditures
among low-income adults. JAMA internal medicine, 177(11):1642–1649.
Berkowitz, S. A., Terranova, J., Randall, L., Cranston, K., Waters, D. B., and Hsu, J.
(2019). Association between receipt of a medically tailored meal program and health
care use. JAMA internal medicine, 179(6):786–793.
35
Bound, J., Jaeger, D. A., and Baker, R. M. (1995). Problems with instrumental variables
estimation when the correlation between the instruments and the endogeneous explana-
tory variable is weak. Journal of the American Statistical Association, 90(430):443–450.
Bronars, S. G. and Grogger, J. (1994). The economic consequences of unwed motherhood:
Using twin births as a natural experiment. The American Economic Review, pages
1141–1156.
Chang, M., Guess, H., and Heyse, J. (1994). Reduction in burden of illness: a new efficacy
measure for prevention trials. Statistics in medicine, 13(18):1807–1814.
Cinelli, C. and Hazlett, C. (2019). Making sense of sensitivity: Extending omitted variable
bias. Journal of the Royal Statistical Society. Series B (Methodological), (forthcoming).
Copas, J. B. and Li, H. G. (1997). Inference for non-random samples. Journal of the Royal
Statistical Society. Series B (Methodological), 59(1):55–95.
Ertefaie, A., Small, D. S., and Rosenbaum, P. R. (2018). Quantitative evaluation of the
trade-off of strengthened instruments and sample size in observational studies. Journal
of the American Statistical Association, 113(523):1122–1134.
Fisher, R. A. (1935). The Design of Experiments. Edinburgh and London: Oliver and
Boyd.
Fogarty, C. B., Lee, K., Kelz, R. R., and Keele, L. J. (2019). Biased encouragements and
heterogeneous effects in an instrumental variable study of emergency general surgical
outcomes. arXiv preprint arXiv:1909.09533.
Goyal, N., Zubizarreta, J. R., Small, D. S., and Lorch, S. A. (2013). Length of stay and
36
readmission among late preterm infants: an instrumental variable approach. Hospital
Pediatrics, 3(1):7–15.
Grieve, R., O’Neill, S., Basu, A., Keele, L., Rowan, K. M., and Harris, S. (2019). Analysis of
benefit of intensive care unit transfer for deteriorating ward patients: A patient-centered
approach to clinical evaluation. JAMA network open, 2(2):e187704–e187704.
Hansen, B. B. (2004). Full matching in an observational study of coaching for the sat.
Journal of the American Statistical Association, 99(467):609–618.
Heller, R., Rosenbaum, P. R., and Small, D. S. (2009). Split samples and design sensitivity
in observational studies. Journal of the American Statistical Association, 104(487):1090–
1101.
Hernán, M. A. and Robins, J. M. (2006). Instruments for causal inference: an epidemiolo-
gist’s dream? Epidemiology, pages 360–372.
Holland, P. W. (1988). Causal inference, path analysis and recursive structural equations
models. ETS Research Report Series, 1988(1):i–50.
Ichino, A., Mealli, F., and Nannicini, T. (2008). From temporary help jobs to permanent
employment: what can we learn from matching estimators and their sensitivity? Journal
of applied econometrics, 23(3):305–327.
Imai, K., Keele, L., and Yamamoto, T. (2010). Identification, inference and sensitivity
analysis for causal mediation effects. Statistical science, pages 51–71.
Imbens, G. W. (2003). Sensitivity to exogeneity assumptions in program evaluation. Amer-
ican Economic Review, 93:126–132.
37
Imbens, G. W. and Angrist, J. D. (1994). Identification and estimation of local average
treatment effects. Econometrica, 62(2):467–475.
Imbens, G. W. and Rosenbaum, P. R. (2005). Robust, accurate confidence intervals with
a weak instrument: Quarter of birth and education. Journal of the Royal Statistical
Society. Series A (Statistics in Society), 168(1):109–126.
Jackson, J. W. and Swanson, S. A. (2015). Toward a clearer portrayal of confounding bias
in instrumental variable applications. Epidemiology (Cambridge, Mass.), 26(4):498.
Kang, H., Kreuels, B., May, J., Small, D. S., et al. (2016). Full matching approach to
instrumental variables estimation with application to the effect of malaria on stunting.
The Annals of Applied Statistics, 10(1):335–364.
Keele, L., Harris, S., Pimentel, S. D., and Grieve, R. (2018). Stronger instruments and
refined covariate balance in an observational study of the effectiveness of prompt admis-
sion to intensive care units. Journal of the Royal Statistical Society: Series A (Statistics
in Society).
Keele, L., Morgan, J. W., et al. (2016). How strong is strong enough? strengthening instru-
ments through matching and weak instrument tests. The Annals of Applied Statistics,
10(2):1086–1106.
Lehmann, D., Li, Y., Saran, R., and Li, Y. (2017). Strengthening instrumental variables
through weighting. Statistics in Biosciences, 9(2):320–338.
Lehmann, E. L. (2004). Elements of large-sample theory. Springer Science & Business
Media.
38
Lin, W., Halpern, S. D., Prasad Kerlin, M., and Small, D. S. (2017). A “placement of
death” approach for studies of treatment effects on icu length of stay. Statistical methods
in medical research, 26(1):292–311.
Lorch, S. A., Baiocchi, M., Ahlberg, C. E., and Small, D. S. (2012). The differential impact
of delivery hospital on the outcomes of premature infants. Pediatrics, 130(2):270–278.
Lu, B., Greevy, R., Xu, X., and Beck, C. (2011). Optimal nonbipartite matching and its
statistical applications. The American Statistician, 65(1):21–30.
Lu, B., Zanutto, E., Hornik, R., and Rosenbaum, P. R. (2001). Matching with doses in an
observational study of a media campaign against drug abuse. Journal of the American
Statistical Association, 96(456):1245–1253.
Lum, K., Ma, E., and Baiocchi, M. (2017). The causal impact of bail on case outcomes for
indigent defendants in new york city. Observational Studies, 3:39–64.
McClellan, M., McNeil, B. J., and Newhouse, J. P. (1994). Does more intensive treatment of
acute myocardial infarction in the elderly reduce mortality?: analysis using instrumental
variables. Jama, 272(11):859–866.
Nattino, G. and Lu, B. (2018). Model assisted sensitivity analyses for hidden bias with
binary outcomes. Biometrics, 74(4):1141–1149.
Neuman, M. D., Rosenbaum, P. R., Ludwig, J. M., Zubizarreta, J. R., and Silber, J. H.
(2014). Anesthesia technique, mortality, and length of stay after hip fracture surgery.
Jama, 311(24):2508–2517.
Neyman, J. S. (1923). On the application of probability theory to agricultural experiments.
39
essay on principles. section 9.(tlanslated and edited by dm dabrowska and tp speed,
statistical science (1990), 5, 465-480). Annals of Agricultural Sciences, 10:1–51.
Pimentel, S. D., Kelz, R. R., Silber, J. H., and Rosenbaum, P. R. (2015). Large, sparse
optimal matching with refined covariate balance in an observational study of the health
outcomes produced by new surgeons. Journal of the American Statistical Association,
110(510):515–527.
Ratkovic, M. and Shiraito, Y. (2014). Strengthening weak instruments by modeling com-
pliance. working paper.
Rosenbaum, P. R. (1989). Sensitivity analysis for matched observational studies with many
ordered treatments. Scandinavian Journal of Statistics, pages 227–236.
Rosenbaum, P. R. (1999). Using quantile averages in matched observational studies. Journal
of the Royal Statistical Society: Series C (Applied Statistics), 48(1):63–78.
Rosenbaum, P. R. (2002). Observational Studies. Springer.
Rosenbaum, P. R. (2004). Design sensitivity in observational studies. Biometrika,
91(1):153–164.
Rosenbaum, P. R. (2005). Heterogeneity and causality. The American Statistician,
59(2):147–152.
Rosenbaum, P. R. (2010). Design of observational studies. Springer.
Rosenbaum, P. R. and Silber, J. H. (2009). Amplification of sensitivity analysis in matched
observational studies. Journal of the American Statistical Association, 104(488):1398–
1405.
40
Rubin, D. B. (1973). Matching to remove bias in observational studies. Biometrics, pages
159–183.
Rubin, D. B. (1974). Estimating causal effects of treatments in randomized and nonran-
domized studies. Journal of educational Psychology, 66(5):688.
Rubin, D. B. (1980). Discussion of "randomization analysis of experimental data in the
fisher randomization test" by d. basu. Journal of the American Statistical Association,
75:591–593.
Rubin, D. B. (1987). Multiple imputation for nonresponse in surveys. John Wiley & Sons.
Rubin, D. B. (1996). Multiple imputation after 18+ years. Journal of the American
statistical Association, 91(434):473–489.
Rubin, D. B. (2008). For objective causal inference, design trumps analysis. The Annals
of Applied Statistics, 2(3):808–840.
Santana-Davila, R., Devisetty, K., Szabo, A., Sparapani, R., Arce-Lara, C., Gore, E. M.,
Moran, A., Williams, C. D., Kelley, M. J., and Whittle, J. (2015). Cisplatin and etoposide
versus carboplatin and paclitaxel with concurrent radiotherapy for stage iii non–small-
cell lung cancer: An analysis of veterans health administration data. Journal of clinical
oncology, 33(6):567.
Scharfstein, D. O., Rotnitzky, A., and Robins, J. M. (1999). Adjusting for nonignorable
drop-out using semiparametric nonresponse models. Journal of the American Statistical
Association, 94(448):1096–1120.
Small, D. S. and Rosenbaum, P. R. (2008). War and wages: the strength of instrumental
41
variables and their sensitivity to unobserved biases. Journal of the American Statistical
Association, 103(483):924–933.
Staiger, D. O. and Stock, J. H. (1994). Instrumental variables regression with weak instru-
ments. National Bureau of Economic Research Cambridge, Mass., USA.
Stock, J. H., Wright, J. H., and Yogo, M. (2002). A survey of weak instruments and
weak identification in generalized method of moments. Journal of Business & Economic
Statistics, 20(4):518–529.
Strauss, W. A. (2007). Partial differential equations: An introduction. John Wiley & Sons.
Stuart, E. A. (2010). Matching methods for causal inference: A review and a look forward.
Statistical science: a review journal of the Institute of Mathematical Statistics, 25(1):1.
Wald, A. (1940). The fitting of straight lines if both variables are subject to error. The
Annals of Mathematical Statistics, 11(3):284–300.
Yang, F., Zubizarreta, J. R., Small, D. S., Lorch, S., and Rosenbaum, P. R. (2014). Dis-
sonant conclusions when testing the validity of an instrumental variable. The American
Statistician, 68(4):253–263.
Zhao, Q. (2019). On sensitivity value of pair-matched observational studies. Journal of the
American Statistical Association, 114(526):713–722.
Zhao, Q. and Small, D. S. (2018). Graphical diagnosis of confounding bias in instrumental
variable analysis. Epidemiology, 29(4):e29–e31.
Zubizarreta, J. R. (2012). Using mixed integer programming for matching in an observa-
tional study of kidney failure after surgery. Journal of the American Statistical Associa-
tion, 107(500):1360–1371.
42
Zubizarreta, J. R., Small, D. S., Goyal, N. K., Lorch, S., Rosenbaum, P. R., et al. (2013).
Stronger instruments via integer programming in an observational study of late preterm
birth outcomes. The Annals of Applied Statistics, 7(1):25–50.
43
Table 1: Covariate balance and average excess travel time of the near/far matching design M0
that uses all samples and the strengthening-IV design M1 that uses half of the samples. The
means of each covariate in “near” and “far” groups are reported in columns “Near” and “Far”.
Std.dif is an abbreviation of “standardized difference”, i.e., weighted difference in means divided
by the pooled standard deviation between the encouraged and control groups before matching;
see Rosenbaum (2010).
Unstrengthened IV Strengthened IV
Number of matched pairs 95,945 47,936
Estimated compliance rate 0.21 0.42
Near Far Std.dif Near Far Std.dif
Excess travel time to
high-level NICU, minutes 5.88 21.26 0.97 2.90 38.13 2.78
Covariates
Birth weight, g 2586 2585 0.00 2586 2585 0.00
Gestational age, weeks 35.13 35.13 0.00 35.16 35.15 0.00
Gestational diabetes, 1/0 0.05 0.05 0.00 0.03 0.04 0.04
Single birth, 1/0 0.83 0.83 0.00 0.86 0.85 0.02
Parity 2.12 2.12 0.00 2.01 2.03 0.02
Mother’s age, years 28.06 28.04 0.00 27.53 27.32 0.04
Mother’s education (scale) 3.69 3.69 0.01 3.64 3.58 0.05
Mother’s race (white or not), 1/0 0.70 0.71 0.00 0.85 0.87 0.04
Mother’s race missing, 1/0 0.09 0.09 0.00 0.06 0.07 0.02
Neighborhood below poverty (fr) 0.13 0.12 0.04 0.12 0.11 0.11
Table 2: Comparing simulated sample size ratio to ARE using the (one-sided) Wilcoxon signed
rank test when compliance (dT ij , dCij) is independent of response under control rCij . The errors
follow standard normal distribution, α = 0.05, β− β0 = 0.1, and ιN = 1− ιA− ιC . We repeat the
simulation 20000 times to approximate the power. ‘SIM’ and ‘THEO’ denote the simulated and
theoretical ratios of the two required sample sizes respectively.
Parameters Normal error Laplace error
Power ιA ιC = 0.5 ιC = 0.6 SIM ιC = 0.5 ιC = 0.6 SIM THEO
0.8
0 2590 1790 1.45 1670 1160 1.44 1.44
(1− ιC)/2 2596 1803 1.44 1675 1177 1.42 1.44
0.7
0 1980 1370 1.45 1265 890 1.42 1.44
(1− ιC)/2 1972 1378 1.43 1261 868 1.45 1.44
0.6
0 1510 1047 1.44 978 677 1.44 1.44
(1− ιC)/2 1517 1046 1.45 974 683 1.43 1.44
Power ιA ιC = 0.4 ιC = 0.7 SIM ιC = 0.5 ιC = 0.6 SIM THEO
0.8
0 4071 1328 3.07 2595 838 3.10 3.06
(1− ιC)/2 4036 1310 3.08 2577 844 3.05 3.06
0.7
0 3092 1014 3.05 1956 647 3.02 3.06
(1− ιC)/2 3096 1019 3.04 1977 644 3.07 3.06
0.6
0 2347 769 3.05 1538 502 3.06 3.06
(1− ιC)/2 2355 769 3.06 1510 491 3.08 3.06
Power ιA ιC = 0.3 ιC = 0.8 SIM ιC = 0.5 ιC = 0.6 SIM THEO
0.8
0 7246 1009 7.17 4594 648 7.09 7.11
(1− ιC)/2 7210 1015 7.10 4590 645 7.12 7.11
0.7
0 5515 775 7.12 3500 493 7.10 7.11
(1− ιC)/2 5500 775 7.10 3542 496 7.14 7.11
0.6
0 4216 590 7.15 2683 379 7.08 7.11
(1− ιC)/2 4225 595 7.10 2700 383 7.05 7.11
Table 3: The simulated power of unstrengthened-IV designM0 and strengthened-IV designM1
for various β, δsup, ξ, and λ1. M0 uses all the 1000 samples and forms 500 matched pairs. M1
only forms half as many matched pairs as the data allows (250 matched pairs). We set τ = 0.01.
Estimated average bias and average sampling standard deviation (SD) σ̂total are reported in the
parenthesis as (Bias/SD). We also report the estimated compliance rate ι̂C . Not shown in the
table, the simulated size (i.e., setting β = δsup = 0) is 0.053 for M0 and 0.054 for M1. 2000
simulations were done for these settings and each setting in the table.
Compliance rate ι̂C
ξ = 1.0 ξ = 1.2 ξ = 4.0 ξ = 5.0
M0 M1 M0 M1 M0 M1 M0 M1
0.24 0.41 0.27 0.46 0.45 0.75 0.46 0.78
Power (Bias/SD)
ξ = 1.0 ξ = 1.2
β = 0.8, δsup = 0.5 M0 M1 M0 M1
λ1 = 1.0 0.70 (0.14/0.27) 0.83 (0.14/0.22) 0.80 (0.12/0.24) 0.93 (0.12/0.20)
λ1 = 1.5 0.66 (0.16/0.27) 0.81 (0.16/0.22) 0.78 (0.14/0.24) 0.91 (0.14/0.20)
λ1 = 2.0 0.64 (0.18/0.27) 0.80 (0.19/0.22) 0.76 (0.16/0.24) 0.90 (0.16/0.20)
λ1 = 2.5 0.60 (0.21/0.27) 0.75 (0.21/0.22) 0.73 (0.19/0.24) 0.87 (0.19/0.20)
λ1 = 3.0 0.57 (0.23/0.27) 0.71 (0.24/0.22) 0.70 (0.20/0.24) 0.84 (0.21/0.20)
Power (Bias/SD)
ξ = 4.0 ξ = 5.0
β = 4, δsup = 10 M0 M1 M0 M1
λ1 = 6.0 0.67 (3.21/0.27) 0.52 (3.37/0.26) 0.78 (3.08/0.26) 0.62 (3.27/0.25)
λ1 = 9.0 0.54 (3.42/0.24) 0.39 (3.61/0.23) 0.68 (3.29/0.23) 0.51 (3.50/0.22)
λ1 = 12.0 0.52 (3.51/0.22) 0.36 (3.70/0.21) 0.66 (3.38/0.21) 0.50 (3.57/0.20)
λ1 = 15.0 0.51 (3.54/0.21) 0.36 (3.74/0.19) 0.65 (3.42/0.20) 0.45 (3.62/0.19)
λ1 = 18.0 0.50 (3.57/0.20) 0.36 (3.76/0.19) 0.63 (3.45/0.19) 0.48 (3.65/0.18)
Figure 1: Panels (a), (b), and (c): power against sample size for three pairs of IVs with different
strength: β − β0 = 0.1, normal error, α = 0.05. Panel (d): sample sizes needed to obtain a
fixed power for the stronger and weaker IV in each pair. Lines with slopes equal to ι2C,2/ι
2
C,1 are
imposed.
(a) Pair 1: (ιC,1 = 0.5, ιC,2 = 0.6) (b) Pair 2: (ιC,1 = 0.4, ιC,2 = 0.7)
(c) Pair 3: (ιC,1 = 0.3, ιC,2 = 0.8) (d) Sample size ratio
Figure 2: Sensitivity plots of the NICU study for the “unstrengthened” IV design M0 and the
“strengthened” IV design M1. x-axis is λ1 and y-axis is τ . Darker shades correspond to larger
values of ∆sup. White lines are isopleths.
(a) (b)
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Supplementary Materials A contains detailed discussion on near/far matching,
Remark 1, Theorem 2, Example 1, the MI paradigm, estimation of σ in model (6),
and the proposed two-step debiased matching algorithm. Supplementary Materials
B contains the statement and proof of a more general version of Theorem 1 (i.e.,
Theorem 5), proofs of Theorems 1, 2, 3, and 4. Supplementary Materials C contains
additional simulations on Theorem 1 and bias due to the unmeasured confounder.
Supplementary Materials A: Discussions and Details on Examples
and Matching
A.1: More details on near/far matching
Near/far matching is a specific application of Lu et al. (2011)’s optimal nonbipartite match-
ing. The goal of near/far matching is to pair babies with similar observed covariates but
different excess travel times. Suppose there are 2I babies prior to matching. An 2I × 2I
distance matrix was defined between every pair of babies. An optimal nonbipartite match-
ing then divides these 2I babies into I nonoverlapping pairs of two babies in an optimal
way, meaning the sum of distances within the I pairs is minimized. The distance between
two babies consists of two parts: a distance that quantifies the distance between the ob-
served covariates of each pair of babies, and a substantial penalty is added to the distance
between any pair of babies whose Z˜ differ (in absoulte value) by at most Λ. For the vanilla
1
matching algorithm M0, we set Λ = 0. To strengthen the IV, we eliminate some babies
in the matching by adding “sinks” (Lu et al., 2001, 2011; Baiocchi et al., 2010). In or-
der to eliminate e babies, e sinks are added to the dataset before matching, yielding a
(2I + e) × (2I + e) distance matrix. The distance between every sink and every baby is
0 and that between every pair of sinks is set to infinity. An optimal match pairs e babies
to the e sinks in a way that minimizes the remaining total sum of distances of I − e/2
pairs of babies, i.e., an optimal size-e set of babies is removed. Throughout our real data
analysis, we used a robust rank-based Mahalanobis distance between observed covariates,
and a penalty caliper Λ = 25 was applied. When strengthening an IV, we added e = I
sinks and eliminated half of the 2I babies.
A.2: Rosenbaum (1989)’s semiparametric dose assignment model
Rosenbaum (1989) considered a different dose assignment model where encouragement
probability is allowed to depend on magnitude of continuous treatments or IVs. According
to Rosenbaum (1989), the dose assignment probability for a multi-valued encouragement
Z˜ follows the semiparametric model below:
P (Z˜11 = z˜11, . . . , Z˜I2 = z˜I2 | F) =
I∏
i=1
2∏
j=1
ξ(z˜ij,xij, uij),
ξ(z˜ij,xij, uij) = α(xij, uij) · exp{χ(z˜ij,xij) + γ · z˜ij · uij},
(16)
where χ(z˜ij,xij) an unknown function, γ an unknown scalar parameter, and α(·, ·) the
normalizing constant. When γ = 0, two individuals with the same X = x have the same
distribution of dose Z˜. When γ > 0, after adjusting for X, individuals with higher values
of U tend to receive higher dose Z˜: for two individuals m and n such that xm = xn,
P (Z˜m = z˜ | F)/P (Z˜n = z˜ | F) ∝ exp{γ · (um − un) · z˜} increases in z˜ when γ > 0 and
2
um > un. Under model (16), Rosenbaum (1989) showed that:
P (Zi1 = 1, Zi2 = 0 | F , Z˜∨, Z˜∧) = P (Z˜i1 > Z˜i2 | F , Z˜∨, Z˜∧)
= P (Z˜i1 > Z˜i2 | F , Z˜i1 ∧ Z˜i2, Z˜i1 ∨ Z˜i2)
=
exp{γ(Z˜i1 − Z˜i2)(ui1 − ui2)}
1 + exp{γ(Z˜i1 − Z˜i2)(ui1 − ui2)}
,
(17)
when Z˜i1 ∧ Z˜i2 6= Z˜i1 ∨ Z˜i2. Equation (17) suggests that dose assignment probability is in
general correlated with the information of continuous doses through Z˜i1∧ Z˜i2 and Z˜i1∨ Z˜i2.
A.3: Illustrating Theorem 2 using the NICU study
We consider a hypothetical version of the dataset introduced in Section 1, where, contrary
to the fact, the single birth indicator is not collected. We further assume that there is no
other unmeasured confounder other than the unmatched single birth indicator. Therefore,
the unmeasured confounder U = 1 if that person’s single birth indicator is 1 and 0 otherwise.
Consider a subset of people A with excess travel time Z˜ ∈ [5 min, 8 min] and U = 1. We
perform a near/far matching as described in Supplementary Materials A.1 and keep track of
whom A are paired to after matching. Consider those among A who are paired to someone
with U = 0 and calculate the probability that these people are assigned encouragement
(i.e., paired to someone with a larger Z˜). According to the Γ sensitivity analysis model
(4), this probability depends only on the difference in U and not on the continuous IVs.
Since Ui1 − Ui2 is held fixed at 1, this probability is a constant and does not vary with the
absolute difference in the continuous IV: |Z˜i1 − Z˜i2| = Z˜i1 ∨ Z˜i2 − Z˜i1 ∧ Z˜i2. Figure 3 plots
this encouragement probability as a function of |Z˜i1 − Z˜i2|. We test the null hypothesis
that this assignment probability is not correlated to |Z˜i1−Z˜i2| using Spearman’s correlation
test, and the p-value is 2.07× 10−6.
3
Figure 3: Probability that a subject with excess travel time Z ∈ [5, 8] and U = 1 is assigned to
encouragement indicator Z = 1 after being matched to a subject with U = 0 and varying excess
travel time. Spearman’s rank correlation test yields a p-value of 2.07× 10−6.
A.4: More details on Example 1
Table 4: Two hypothetical scenario where the single birth indicator and the race indicator
(white or not) are not observed or matched on.
U = single birth indicator U = race indicator (white or not)
Original (M0) Strengthened (M1) Original (M0) Strengthened (M1)
Strength 0.21 0.42 0.22 0.45
Difference in U 1.89× 10−3 5.01× 10−3 7.96× 10−2 2.08× 10−1
Bias δ × 9.16× 10−3 δ × 1.19× 10−2 δ × 0.37 δ × 0.46
Ratio of bias ∆ 1.30 > 1 1.26 > 1
4
A.5: Details on constructing a finite-sample sensitivity interval using the MI paradigm
We regard {Ui1, Ui2, i = 1, ..., I} as missing covariates and describe how to construct a finite-
sample sensitivity interval using the multiple imputation (MI) paradigm. Note that the
only difference between the standard MI paradigm and our procedure here is that the data-
generating process of U is the sensitivity analysis model under consideration and completely
known (Rubin, 1987; Ichino et al., 2008). Fix (δ,θ) ∈ I and impute {(Ui1, Ui2), i = 1, ..., I}
using the parametric model relating U to X and Z˜ discussed above. For each imputed
dataset k, Theorem 3 implies a bias-corrected point estimate of β is
β̂IV,k = β̂IV − B̂ias(β̂IV) = β̂IV − δ ·
∑I
i=1(Zi1 − Zi2)(U (k)i1 − U (k)i2 )∑I
i=1(Zi1 − Zi2)(Di1 −Di2)
, k = 1, . . . , K,
where {(U (k)i1 , U (k)i2 ), i = 1, ..., I} is the k-th imputed set of U , and the associated vari-
ance is Var(β̂IV,k) = 2σ2 · [I · ι̂2C ]−1. According to Rubin’s rule, the overall estimate
for β is K−1
∑K
k=1 β̂IV,k, and the variance of the estimate = within-imputation variance +
across-imputation variance (Rubin, 1996). So the estimated variance of K−1
∑K
k=1 β̂IV,k is
σ̂2total =
1 +K−1
K − 1
K∑
k=1
(
β̂IV,k −K−1
K∑
k=1
β̂IV,k
)2
+
2σ2
I · ι̂2C
. (18)
Therefore, for each fixed (δ,θ) ∈ I, a 100(1− α)% confidence interval of β is
CI(δ,θ) =
[
K−1
K∑
k=1
β̂IV,k − t−1ν (1− α/2) · σ̂total, K−1
K∑
k=1
β̂IV,k + t
−1
ν (1− α/2) · σ̂total
]
,
where t−1ν is the quantile function of the Student’s t-distribution with degrees of freedom
ν = (K − 1)
[
1 +
2σ2 · [I · ι̂2C ]−1
1+K−1
K−1
∑K
k=1
(
β̂IV,k −K−1
∑K
k=1 β̂IV,k
)2
]2
.
Then a 100(1 − α)% sensitivity interval (SI) of β given the sensitivity zone I is SI =⋃
(δ,θ)∈I CI(δ,θ).
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We further incorporate the uncertainty of estimating σ in the MI paradigm by replacing
Var(β̂IV,k) = 2σ2 · [I · ι̂2C ]−1 in (18) with K−1
∑K
k=1 2σ̂
2
k · [I · ι̂2C ]−1, resulting in (13), where σ̂k
estimates σ in the k-th imputed dataset under some parsimonious model of f(Xn) in (6).
A.6: Estimation of σ in the outcome generating model (6)
Under the outcome generating model (6), since {n : n = 1, . . . , N} |= {(Z˜n,Xn, Un) :
n = 1, . . . , N}, by Definition 1, we have {n : n = 1, . . . , N} |= M. Thus, T1, . . . , TI ,
C1, . . . , CI are i.i.d. with expectation zero and variance σ2. Thus, by the law of large
numbers, we have
1
I
I∑
i=1
(i1 − i2)2 = 1
I
I∑
i=1
(T i − Ci)2 a.s.−−→ 2σ2.
Conditional on exact matching Xi1 = Xi2, we have
(i1 − i2)2 = (Ri1 −Ri2 − βDi1 + βDi2 − δUi1 + δUi2)2
= (Ri1 −Ri2)2 + β2 · (Di1 −Di2)2 + δ2 · (Ui1 − Ui2)2 − β · (Ri1 −Ri2)(Di1 −Di2)
− δ · (Ri1 −Ri2)(Ui1 − Ui2) + β · δ · (Di1 −Di2)(Ui1 − Ui2).
Assume that under the matching algorithmM, we have 1
I
∑I
i=1(Ri1 −Ri2)2
p−→ EM[(Ri1 −
Ri2)
2], 1
I
∑I
i=1(Di1 − Di2)2
p−→ EM[(Di1 − Di2)2], 1I
∑I
i=1(Ui1 − Ui2)2
p−→ EM[(Ui1 − Ui2)2],
1
I
∑I
i=1(Ri1−Ri2)(Di1−Di2)
p−→ EM[(Ri1−Ri2)(Di1−Di2)], 1I
∑I
i=1(Ri1−Ri2)(Ui1−Ui2)
p−→
EM[(Ri1−Ri2)(Ui1−Ui2)], and 1I
∑I
i=1(Di1−Di2)(Ui1−Ui2)
p−→ EM[(Di1−Di2)(Ui1−Ui2)].
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Thus, we can estimate 2σ2 by
2σ̂2 =
1
I
I∑
i=1
(Ri1 −Ri2)2 + β2 · 1
I
I∑
i=1
(Di1 −Di2)2 + δ2 · 1
I
I∑
i=1
(Ui1 − Ui2)2
− β · 1
I
I∑
i=1
(Ri1 −Ri2)(Di1 −Di2)− δ · 1
I
I∑
i=1
(Ri1 −Ri2)(Ui1 − Ui2)
+ β · δ · 1
I
I∑
i=1
(Di1 −Di2)(Ui1 − Ui2).
However, we cannot get 2σ̂2 without positing some further models. For example, note that
although the last term 1
I
∑I
i=1(Di1−Di2)(Ui1−Ui2) can be approximated by 1I
∑I
i=1(Di1−
Di2)E[(Ui1 − Ui2) | Di1, Di2,Xi1,Xi2, Z˜i1, Z˜i2], it requires imposing an model on E[(Ui1 −
Ui2) | Di1, Di2,Xi1,Xi2, Z˜i1, Z˜i2] in addition to E[U | X, Z˜] because U 6⊥⊥ D | X, Z˜.
A.7: A two-step debiased matching algorithm
Our proposed matching algorithm consists of two stages. In the first stage, we construct an
IV using a matching algorithm (e.g., optimal non-bipartite matching) without strengthen-
ing the IV. Denote the difference in means of each observed covariate Xi in this design as
δi. The second stage uses the mixed integer programming (MIP) framework introduced in
Zubizarreta (2012). We impose a constraint to ensure that the difference in the continuous
IV formed by the second-stage matching is on average at least k times as large as that
in the initial IV formed by the first-stage matching, where k ∈ [1,+∞). In practice, we
can treat k as a tuning parameter and try different values of k to ensure both a increase
in the average paired difference of Z˜ (i.e., k not too small), and no dramatic decrease in
the sample size (i.e., k not too large). We also add constraints to make sure that the
difference in means of each observed covariate Xi can be no larger than δi. Algorithm 1 in
Supplementary Materials A.8 summarizes the proposed matching algorithm. For more de-
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tails of integer programming and its application to statistical matching, see Supplementary
Materials A.8, Zubizarreta (2012), and Zubizarreta et al. (2013).
Remark 2. By constraining the difference in means of each observed covariate in M1
to be no larger than that in M0, we make sure no bias is introduced as a by-product of
the strengthening-IV algorithm when f(X) is linear in X as in (8). One can put further
constraints on the higher moments and even marginal distributions of Xi and interactions
XiXj. These objectives can all be incorporated in Zubizarreta (2012)’s mixed-integer-
programming (MIP) framework.
We illustrate the proposed matching algorithm using a subset of NICU data (2005 NICU
study). We consider the following six covariates as a simple example: the birth weight in
kilos, gestational age in weeks, gestational diabetes indicator, single birth indicator, parity,
and mother’s age in years. Table 5 contrasts the standardized difference of each of the six
covariates in three designs: a first design that uses the vanilla near/far matching algorithm
(M0), a second design that strengthens the IV by throwing away half of the samples as in
Baiocchi et al. (2010) (M1), and a third design that uses the proposed two-stage debiased
matching algorithm (Mtwo-stage). Equation (8) suggests the bias due to inexact matching in
X is amplified by the imperfect compliance (see also Jackson and Swanson, 2015; Zhao and
Small, 2018). To account for this, the standardized difference of each covariate in Table 5
is further complemented by a version of it that is normalized by the estimated compliance
rate ι̂C . From Table 5, we see some covariates have worse balance in designM1 compared
to M0, before the standardized difference is normalized by ι̂C . Even after we take into
account thatM1 has higher ι̂C , many covariates are still less balanced compared toM0.
See numbers in bold in the parentheses. On the other hand, the standardized difference
of every covariate in Mtwo-stage is, by the design of our proposed matching algorithm, no
larger than that inM0 before being divided by ι̂C . In fact, since ι̂C increases inMtwo-stage
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compared to M0, the normalized standardized differences are guaranteed to be smaller
than those in M0. Meanwhile, Mtwo-stage significantly strengthened the IV compared to
M0, with the estimated compliance rate 0.51 > 0.26.
Table 5: Covariate balance in three designs: the vanilla near/far matching algorithmM0,
the strengthening-IV algorithm M1 that throws away half of data, and the two-stage
debiased matching algorithm Mtwo-stage. We only focus on the 2005 NICU data here.
Standardized difference of each covariate after matching is reported, followed by a version
of it that is normalized by the estimated compliance rate in the parenthesis.
M0 M1 Mtwo-stage
Estimated compliance rate 0.26 0.45 0.51
Covariates
Birth weight, g 0.00 (0.00) 0.00 (0.01) 0.00 (0.00)
Gestational age, weeks 0.00 (0.00) 0.00 (0.01) 0.00 (0.00)
Gestational diabetes, 1/0 0.00 (0.01) 0.01 (0.02) 0.00 (0.00)
Single birth, 1/0 0.00 (0.01) 0.00 (0.00) 0.00 (0.00)
Parity 0.01 (0.05) 0.01 (0.03) 0.00 (0.01)
Mother’s age, years 0.00 (0.01) 0.00 (0.01) 0.00 (0.00)
Number of matched pairs 5161 2579 3138
A.8: An overview on matching via mixed integer programming (MIP) and a two-
step debiased matching algorithm in detail
We start by briefly introducing the integer programming and its connection to statistical
matching. Readers who are interested in more details should refer to Zubizarreta (2012);
Zubizarreta et al. (2013).
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An integer program takes the form
minimizea ηTa subject to Ba ≤ b,a ≥ 0 with a integer.
In the context of statistical matching, the decision variable a is further binary. Suppose
there are L subjects in the study and let alm, 1 ≤ l < m ≤ L be binary variables such that
alm = 1 if the subject l and m are paired. As introduced in Zubizzareta (2012, 2013), the
following constraints need to be imposed:
1. Each subject l appears in at most one matched pair:
l−1∑
m=1
aml +
L∑
m=l+1
alm ≤ 1;
2. Balance the means of observed covariate Xi:∣∣∣∣∣
L−1∑
l=1
L∑
m=l+1
almvi,l −
L−1∑
l=1
L∑
m=l+1
almvi,m
∣∣∣∣∣ ≤ δi
L−1∑
l=1
L∑
m=l+1
alm,
where vi,l is the covariate Xi of the subject l and δi is the difference in means of
covariate Xi in designM0;
3. Force pairs to differ with respect to the mean of the IV:
L−1∑
l=1
L∑
m=l+1
almvl −
L−1∑
l=1
L∑
m=l+1
almvm ≥ φ
L−1∑
l=1
L∑
m=l+1
alm,
where vl here represents the IV of the subject l and φ encodes the strength of the
strengthening-IV design.
Finally, the objective function encodes our desire to have as many matched pairs as
possible:
maximize
L−1∑
l=1
L∑
m=l+1
alm.
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Other constraints, such as the fine-balance and near-fine balance constraints, can also
be formulated as linear constraints and added to the above mathematical program. For
detailed discussion, see Zubizarreta (2012); Zubizarreta et al. (2013).
Algorithm 1 summarizes the two-step matching algorithm proposed in Section 6.1.
Algorithm 1 A two-step debiased matching algorithm
1: Apply optimal non-bipartite matching without strengthening the IV.
2: Output δi, the difference in means of observed covariates X1, X2, ..., Xp.
3: For a fixed φ, solve the following integer program:
maximize
L−1∑
l=1
L∑
m=l+1
alm
subject to
l−1∑
m=1
aml +
L∑
m=l+1
alm ≤ 1,∣∣∣∣∣
L−1∑
l=1
L∑
m=l+1
almvi,l −
L−1∑
l=1
L∑
m=l+1
almvi,m
∣∣∣∣∣ ≤ δi
L−1∑
l=1
L∑
m=l+1
alm, i = 1, . . . , p,
L−1∑
l=1
L∑
m=l+1
almvl −
L−1∑
l=1
L∑
m=l+1
almvm ≥ φ
L−1∑
l=1
L∑
m=l+1
alm.
4: Tune the parameter φ to balance the trade-off between the average paired difference of
the IV and the sample size.
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Supplementary Materials B: Proofs
B.1: Proof of Theorem 1
Theorem 5 (The complete and general form of Theorem 1). Consider a sequence of testing
problems consisting of a null hypothesis H0 : β = β0 versus H1 = βn. Suppose that βn =
β0 + ∆/
√
n+ o(1/
√
n) and without loss of generality, suppose that ∆ > 0. Let piI(·) be the
power function of the one-sided Wilcoxon signed rank test (or the sign test) when testing the
proportional treatment effect model in a randomized encouragement design using I matched
pairs. Let In be the minimal number of matched pairs needed such that piIn(β0) ≤ α and
piIn(βn) ≥ γ for some α ∈ (0, 1) and γ ∈ (α, 1). Let In,1 and In,2 be the number of
matched pairs needed for two given sequences of tests using two different valid IVs: IV
I with parameters %1 = (ιC,1, ιA,1, ιN,1, µC,1, µA,1, µN,1) and IV II with parameters %2 =
(ιC,2, ιA,2, ιN,2, µC,2, µA,2, µN,2). Let f(x) be the density function of the error term i, and
let f ′(x) be the derivative function of f(x). Suppose that f is continuously differentiable,
lim
x→∞
f(x) = 0, and f ∈ L2. We have under the Wilcoxon signed rank test,
lim
n→∞
In,1
In,2
=
ψ2wilc(ιC,2, ιA,2, ιN,2, µC,2, µA,2, µN,2)
ψ2wilc(ιC,1, ιA,1, ιN,1, µC,1, µA,1, µN,1)
,
where
ψwilc(ιC , ιA, ιN , µC , µA, µN) = A · ι4C +B1 · ι3C ιA +B2 · ι2C ι2A +B3 · ιC ι3A
+ C1 · ι3C ιN + C2 · ι2C ι2N + C3 · ιC ι3N
+D1 · ι2C ιA ιN +D2 · ιC ι2A ιN +D3 · ιC ιA ι2N ,
with
A = 2 · {f ∗ f}(0), B1 = 6 · {f ∗ f}(µA − µC),
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B2 = 4 · {f ∗ f}(0) + 2 · {f ∗ f}(2µA − 2µC), B3 = 2 · {f ∗ f}(µA − µC),
C1 = 6 · {f ∗ f}(µN − µC), C2 = 4 · {f ∗ f}(0) + 2 · {f ∗ f}(2µN − 2µC),
C3 = 2 · {f ∗ f}(µN − µC), D1 = 8 · {f ∗ f}(µA − µN) + 4 · {f ∗ f}(µA + µN − 2µC),
D2 = 4 · {f ∗ f}(µN − µC) + 2 · {f ∗ f}(2µA − µN − µC),
D3 = 4 · {f ∗ f}(µA − µC) + 2 · {f ∗ f}(µA − 2µN + µC),
where {f ∗ g} denotes the convolution of two functions f and g, that is, {f ∗ g}(x) =∫ +∞
−∞ f(x − y)g(y)dy. Under the same set-up but testing the null hypothesis using the sign
test, we have
lim
n→∞
In,1
In,2
=
ψ2sign(ιC,2, ιA,2, ιN,2, µC,2, µA,2, µN,2)
ψ2sign(ιC,1, ιA,1, ιN,1, µC,1, µA,1, µN,1)
,
where
ψsign = ι
2
C f(0) + ιC ιN f(µN − µC) + ιC ιA f(−µA + µC).
Lemma 1. Given two functions f and g, let {f ∗ g} denote the convolution of f and g,
that is, {f ∗ g}(x) = ∫ +∞−∞ f(x− y)g(y)dy. Let F (x) be a distribution function, f(x) be the
corresponding density function, and f ′(x) be the derivative function of f(x). Suppose that
f ′ is continuous and f ∈ L2. If f(x)→ 0 as x→∞, we have,
F ∗ f ′ = f ∗ f.
If we additionally assume that f(x) = f(−x) for any x ∈ R, we have for any x ∈ R,
{F ∗ f ′}(x) = {F ∗ f ′}(−x), {f ∗ f}(x) = {f ∗ f}(−x).
Proof. For any x ∈ R, since lim
x→−∞
F (x) = 0, lim
x→+∞
F (x) = 1, lim
x→−∞
f(x) = lim
x→+∞
f(x) = 0,
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we have
{f ∗ f}(x) =
∫ +∞
−∞
f(x− y)f(y)dy = −F (x− y)f(y)|+∞−∞ +
∫ +∞
−∞
F (x− y)f ′(y)dy
=
∫ +∞
−∞
F (x− y)f ′(y)dy = {F ∗ f ′}(x).
If for any x ∈ R, we have f(x) = f(−x), then we have
{f ∗ f}(x) =
∫ +∞
−∞
f(x− y)f(y)dy =
∫ +∞
−∞
f(−x+ y)f(y)dy
=
∫ +∞
−∞
f(y)f(x+ y)dy =
∫ +∞
−∞
f(y)f(−x− y)dy
= {f ∗ f}(−x).
Thus, we have
{F ∗ f ′}(x) = {f ∗ f}(x) = {f ∗ f}(−x) = {F ∗ f ′}(−x).
Proof of Theorem 5. Under the setting as in Section 3.1, let G be the distribution function
of Yi − β0Di. As described in Ertefaie et al. (2018), we have G(x) =
∑8
i=1Gi(x) where
G1(x) = ι
2
C F (x− β + β0),
G2(x) = ιC ιN F (x+ µN − µC − β + β0),
G3(x) = ιC ιN F (x− µN + µC),
G4(x) = ιC ιA F (x− µA + µC − β + β0),
G5(x) = ιC ιA F (x+ µA − µC),
G6(x) = (ι
2
A + ι
2
N) F (x),
G7(x) = ιA ιN F (x− µA + µN − β + β0),
G8(x) = ιA ιN F (x− µN + µA + β − β0).
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Let g(x) = G′(x) =
∑8
i=1 gi(x), where gi(x) = G
′
i(x) for all i. Following Example 3.3.6 in
Lehmann (2004), we just need to figure out ϕ′(β0), the derivative of ϕ(β) = Pβ(X+Y > 0)
at β = β0, where X ∼ G, Y ∼ G, X and Y are independent. Then the ARE under the
Wilcoxon signed rank test is the ratio of {ϕ′(β0)}2 under %1 = (ιC,1, ιA,1, ιN,1, µC,1, µA,1, µN,1)
and %2 = (ιC,2, ιA,2, ιN,2, µC,2, µA,2, µN,2). We have
1− ϕ(β) = Pβ(X + Y ≤ 0) =
∫∫
x+y≤0
g(x, y)dydx
=
∫ +∞
−∞
[ ∫ −x
−∞
g(y)dy
]
g(x)dx =
∫ +∞
−∞
G(−x)g(x)dx
=
8∑
i=1
8∑
j=1
∫ +∞
−∞
Gi(−x)gj(x)dx.
Thus, we have,
ϕ′(β0) = −
8∑
i=1
8∑
j=1
∂
∂β
∫ +∞
−∞
Gi(−x)gj(x)dx
∣∣∣
β=β0
=
8∑
i=1
8∑
j=1
(
−
∫ +∞
−∞
∂
∂β
[
Gi(−x)gj(x)
]
dx
∣∣∣
β=β0
)
.
As discussed in Section 3.1, if the IV is valid, then F (·) is symmetric about zero. We
have
−
∫ +∞
−∞
∂
∂β
[
G1(−x)g1(x)
]
dx
∣∣∣
β=β0
= ι4C
(∫ +∞
−∞
f 2(x)dx+
∫ +∞
−∞
F (−x)f ′(x)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G1(−x)g2(x)
]
dx
∣∣∣
β=β0
= ι3C ιN
(∫ +∞
−∞
f(x)f(x+ µN − µC)dx
+
∫ +∞
−∞
F (−x)f ′(x+ µN − µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G1(−x)g3(x)
]
dx
∣∣∣
β=β0
= ι3C ιN
(∫ +∞
−∞
f(x)f(x− µN + µC)dx
)
,
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−
∫ +∞
−∞
∂
∂β
[
G1(−x)g4(x)
]
dx
∣∣∣
β=β0
= ι3C ιA
(∫ +∞
−∞
f(x)f(x− µA + µC)dx
+
∫ +∞
−∞
F (−x)f ′(x− µA + µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G1(−x)g5(x)
]
dx
∣∣∣
β=β0
= ι3C ιA
(∫ +∞
−∞
f(x)f(x+ µA − µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G1(−x)g6(x)
]
dx
∣∣∣
β=β0
= ι2C (ι
2
A + ι
2
N)
(∫ +∞
−∞
f 2(x)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G1(−x)g7(x)
]
dx
∣∣∣
β=β0
= ι2C ιA ιN
(∫ +∞
−∞
f(x)f(x− µA + µN)dx
+
∫ +∞
−∞
F (−x)f ′(x− µA + µN)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G1(−x)g8(x)
]
dx
∣∣∣
β=β0
= ι2C ιA ιN
(∫ +∞
−∞
f(x)f(x− µN + µA)dx
−
∫ +∞
−∞
F (−x)f ′(x− µN + µA)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G2(−x)g1(x)
]
dx
∣∣∣
β=β0
= ι3C ιN
(∫ +∞
−∞
f(x− µN + µC)f(x)dx
+
∫ +∞
−∞
F (−x+ µN − µC)f ′(x)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G2(−x)g2(x)
]
dx
∣∣∣
β=β0
= ι2C ι
2
N
(∫ +∞
−∞
f(x− µN + µC)f(x+ µN − µC)dx
+
∫ +∞
−∞
F (−x+ µN − µC)f ′(x+ µN − µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G2(−x)g3(x)
]
dx
∣∣∣
β=β0
= ι2C ι
2
N
(∫ +∞
−∞
f 2(x− µN + µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G2(−x)g4(x)
]
dx
∣∣∣
β=β0
= ι2C ιA ιN
(∫ +∞
−∞
f(x− µN + µC)f(x− µA + µC)dx
+
∫ +∞
−∞
F (−x+ µN − µC)f ′(x− µA + µC)dx
)
,
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−
∫ +∞
−∞
∂
∂β
[
G2(−x)g5(x)
]
dx
∣∣∣
β=β0
= ι2C ιA ιN
(∫ +∞
−∞
f(x− µN + µC)f(x+ µA − µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G2(−x)g6(x)
]
dx
∣∣∣
β=β0
= (ιC ι
2
A ιN + ιC ι
3
N)
(∫ +∞
−∞
f(x− µN + µC)f(x)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G2(−x)g7(x)
]
dx
∣∣∣
β=β0
= ιC ιA ι
2
N
(∫ +∞
−∞
f(x− µN + µC)f(x− µA + µN)dx
+
∫ +∞
−∞
F (−x+ µN − µC)f ′(x− µA + µN)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G2(−x)g8(x)
]
dx
∣∣∣
β=β0
= ιC ιA ι
2
N
(∫ +∞
−∞
f(x− µN + µC)f(x− µN + µA)dx
−
∫ +∞
−∞
F (−x+ µN − µC)f ′(x− µN + µA)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G3(−x)g1(x)
]
dx
∣∣∣
β=β0
= ι3C ιN
(∫ +∞
−∞
F (−x− µN + µC)f ′(x)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G3(−x)g2(x)
]
dx
∣∣∣
β=β0
= ι2C ι
2
N
(∫ +∞
−∞
F (−x− µN + µC)f ′(x+ µN − µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G3(−x)g3(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G3(−x)g4(x)
]
dx
∣∣∣
β=β0
= ι2C ιA ιN
(∫ +∞
−∞
F (−x− µN + µC)f ′(x− µA + µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G3(−x)g5(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G3(−x)g6(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G3(−x)g7(x)
]
dx
∣∣∣
β=β0
= ιC ιA ι
2
N
(∫ +∞
−∞
F (−x− µN + µC)f ′(x− µA + µN)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G3(−x)g8(x)
]
dx
∣∣∣
β=β0
= ιC ιA ι
2
N
(
−
∫ +∞
−∞
F (−x− µN + µC)f ′(x− µN + µA)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G4(−x)g1(x)
]
dx
∣∣∣
β=β0
= ι3C ιA
(∫ +∞
−∞
f(x+ µA − µC)f(x)dx
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+∫ +∞
−∞
F (−x− µA + µC)f ′(x)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G4(−x)g2(x)
]
dx
∣∣∣
β=β0
= ι2C ιA ιN
(∫ +∞
−∞
f(x+ µA − µC)f(x+ µN − µC)dx
+
∫ +∞
−∞
F (−x− µA + µC)f ′(x+ µN − µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G4(−x)g3(x)
]
dx,
∣∣∣
β=β0
= ι2C ιA ιN
(∫ +∞
−∞
f(x+ µA − µC)f(x− µN + µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G4(−x)g4(x)
]
dx
∣∣∣
β=β0
= ι2C ι
2
A
(∫ +∞
−∞
f(x+ µA − µC)f(x− µA + µC)dx,
+
∫ +∞
−∞
F (−x− µA + µC)f ′(x− µA + µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G4(−x)g5(x)
]
dx
∣∣∣
β=β0
= ι2C ι
2
A
(∫ +∞
−∞
f 2(x+ µA − µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G4(−x)g6(x)
]
dx
∣∣∣
β=β0
= (ιC ι
3
A + ιC ιA ι
2
N)
(∫ +∞
−∞
f(x+ µA − µC)f(x)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G4(−x)g7(x)
]
dx
∣∣∣
β=β0
= ιC ι
2
A ιN
(∫ +∞
−∞
f(x+ µA − µC)f(x− µA + µN)dx
+
∫ +∞
−∞
F (−x− µA + µC)f ′(x− µA + µN)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G4(−x)g8(x)
]
dx
∣∣∣
β=β0
= ιC ι
2
A ιN
(∫ +∞
−∞
f(x+ µA − µC)f(x− µN + µA)dx
−
∫ +∞
−∞
F (−x− µA + µC)f ′(x− µN + µA)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G5(−x)g1(x)
]
dx
∣∣∣
β=β0
= ι3C ιA
(∫ +∞
−∞
F (−x+ µA − µC)f ′(x)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G5(−x)g2(x)
]
dx
∣∣∣
β=β0
= ι2C ιA ιN
(∫ +∞
−∞
F (−x+ µA − µC)f ′(x+ µN − µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G5(−x)g3(x)
]
dx
∣∣∣
β=β0
= 0,
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−
∫ +∞
−∞
∂
∂β
[
G5(−x)g4(x)
]
dx
∣∣∣
β=β0
= ι2C ι
2
A
(∫ +∞
−∞
F (−x+ µA − µC)f ′(x− µA + µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G5(−x)g5(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G5(−x)g6(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G5(−x)g7(x)
]
dx
∣∣∣
β=β0
= ιC ι
2
A ιN
(∫ +∞
−∞
F (−x+ µA − µC)f ′(x− µA + µN)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G5(−x)g8(x)
]
dx
∣∣∣
β=β0
= ιC ι
2
A ιN
(
−
∫ +∞
−∞
F (−x+ µA − µC)f ′(x− µN + µA)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G6(−x)g1(x)
]
dx
∣∣∣
β=β0
= (ι2C ι
2
A + ι
2
C ι
2
N)
(∫ +∞
−∞
F (−x)f ′(x)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G6(−x)g2(x)
]
dx
∣∣∣
β=β0
= (ιC ι
2
A ιN + ιC ι
3
N)
(∫ +∞
−∞
F (−x)f ′(x+ µN − µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G6(−x)g3(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G6(−x)g4(x)
]
dx
∣∣∣
β=β0
= (ιC ι
3
A + ιC ιA ι
2
N)
(∫ +∞
−∞
F (−x)f ′(x− µA + µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G6(−x)g5(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G6(−x)g6(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G6(−x)g7(x)
]
dx
∣∣∣
β=β0
= (ι3A ιN + ιA ι
3
N)
(∫ +∞
−∞
F (−x)f ′(x− µA + µN)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G6(−x)g8(x)
]
dx
∣∣∣
β=β0
= (ι3A ιN + ιA ι
3
N)
(
−
∫ +∞
−∞
F (−x)f ′(x− µN + µA)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G7(−x)g1(x)
]
dx
∣∣∣
β=β0
= ι2C ιA ιN
(∫ +∞
−∞
f(x+ µA − µN)f(x)dx
+
∫ +∞
−∞
F (−x− µA + µN)f ′(x)dx
)
,
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−
∫ +∞
−∞
∂
∂β
[
G7(−x)g2(x)
]
dx
∣∣∣
β=β0
= ιC ιA ι
2
N
(∫ +∞
−∞
f(x+ µA − µN)f(x+ µN − µC)dx
+
∫ +∞
−∞
F (−x− µA + µN)f ′(x+ µN − µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G7(−x)g3(x)
]
dx
∣∣∣
β=β0
= ιC ιA ι
2
N
(∫ +∞
−∞
f(x+ µA − µN)f(x− µN + µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G7(−x)g4(x)
]
dx
∣∣∣
β=β0
= ιC ι
2
A ιN
(∫ +∞
−∞
f(x+ µA − µN)f(x− µA + µC)dx
+
∫ +∞
−∞
F (−x− µA + µN)f ′(x− µA + µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G7(−x)g5(x)
]
dx
∣∣∣
β=β0
= ιC ι
2
A ιN
(∫ +∞
−∞
f(x+ µA − µN)f(x+ µA − µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G7(−x)g6(x)
]
dx
∣∣∣
β=β0
= (ι3A ιN + ιA ι
3
N)
(∫ +∞
−∞
f(x+ µA − µN)f(x)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G7(−x)g7(x)
]
dx
∣∣∣
β=β0
= ι2A ι
2
N
(∫ +∞
−∞
f(x+ µA − µN)f(x− µA + µN)dx
+
∫ +∞
−∞
F (−x− µA + µN)f ′(x− µA + µN)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G7(−x)g8(x)
]
dx
∣∣∣
β=β0
= ι2A ι
2
N
(∫ +∞
−∞
f(x+ µA − µN)f(x− µN + µA)dx
−
∫ +∞
−∞
F (−x− µA + µN)f ′(x− µN + µA)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G8(−x)g1(x)
]
dx
∣∣∣
β=β0
= ι2C ιA ιN
(
−
∫ +∞
−∞
f(x+ µN − µA)f(x)dx
+
∫ +∞
−∞
F (−x− µN + µA)f ′(x)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G8(−x)g2(x)
]
dx
∣∣∣
β=β0
= ιC ιA ι
2
N
(
−
∫ +∞
−∞
f(x+ µN − µA)f(x+ µN − µC)dx
+
∫ +∞
−∞
F (−x− µN + µA)f ′(x+ µN − µC)dx
)
,
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−
∫ +∞
−∞
∂
∂β
[
G8(−x)g3(x)
]
dx
∣∣∣
β=β0
= ιC ιA ι
2
N
(
−
∫ +∞
−∞
f(x+ µN − µA)f(x− µN + µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G8(−x)g4(x)
]
dx
∣∣∣
β=β0
= ιC ι
2
A ιN
(
−
∫ +∞
−∞
f(x+ µN − µA)f(x− µA + µC)dx
+
∫ +∞
−∞
F (−x− µN + µA)f ′(x− µA + µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G8(−x)g5(x)
]
dx
∣∣∣
β=β0
= ιC ι
2
A ιN
(
−
∫ +∞
−∞
f(x+ µN − µA)f(x+ µA − µC)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G8(−x)g6(x)
]
dx
∣∣∣
β=β0
= (ι3A ιN + ιA ι
3
N)
(
−
∫ +∞
−∞
f(x+ µN − µA)f(x)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G8(−x)g7(x)
]
dx
∣∣∣
β=β0
= ι2A ι
2
N
(
−
∫ +∞
−∞
f(x+ µN − µA)f(x− µA + µN)dx
+
∫ +∞
−∞
F (−x− µN + µA)f ′(x− µA + µN)dx
)
,
−
∫ +∞
−∞
∂
∂β
[
G8(−x)g8(x)
]
dx
∣∣∣
β=β0
= ι2A ι
2
N
(
−
∫ +∞
−∞
f(x+ µN − µA)f(x− µN + µA)dx
−
∫ +∞
−∞
F (−x− µN + µA)f ′(x− µN + µA)dx
)
,
As discussed in Section 3.1, if the IV is valid, we have f(x) = f(−x) for any x ∈ R.
Invoking Lemma 1, we can rewrite these 64 terms as
−
∫ +∞
−∞
∂
∂β
[
G1(−x)g1(x)
]
dx
∣∣∣
β=β0
= ι4C
(
2 · {f ∗ f}(0)
)
,
−
∫ +∞
−∞
∂
∂β
[
G1(−x)g2(x)
]
dx
∣∣∣
β=β0
= ι3C ιN
(
2 · {f ∗ f}(µN − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G1(−x)g3(x)
]
dx
∣∣∣
β=β0
= ι3C ιN
(
{f ∗ f}(µN − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G1(−x)g4(x)
]
dx
∣∣∣
β=β0
= ι3C ιA
(
2 · {f ∗ f}(µA − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G1(−x)g5(x)
]
dx
∣∣∣
β=β0
= ι3C ιA
(
{f ∗ f}(µA − µC)
)
,
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−
∫ +∞
−∞
∂
∂β
[
G1(−x)g6(x)
]
dx
∣∣∣
β=β0
= ι2C (ι
2
A + ι
2
N)
(
{f ∗ f}(0)
)
,
−
∫ +∞
−∞
∂
∂β
[
G1(−x)g7(x)
]
dx
∣∣∣
β=β0
= ι2C ιA ιN
(
2 · {f ∗ f}(µA − µN)
)
,
−
∫ +∞
−∞
∂
∂β
[
G1(−x)g8(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G2(−x)g1(x)
]
dx
∣∣∣
β=β0
= ι3C ιN
(
2{f ∗ f}(µN − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G2(−x)g2(x)
]
dx
∣∣∣
β=β0
= ι2C ι
2
N
(
2 · {f ∗ f}(2µN − 2µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G2(−x)g3(x)
]
dx
∣∣∣
β=β0
= ι2C ι
2
N
(
{f ∗ f}(0)
)
,
−
∫ +∞
−∞
∂
∂β
[
G2(−x)g4(x)
]
dx
∣∣∣
β=β0
= ι2C ιA ιN
(
2 · {f ∗ f}(µA − µN)
)
,
−
∫ +∞
−∞
∂
∂β
[
G2(−x)g5(x)
]
dx
∣∣∣
β=β0
= ι2C ιA ιN
(
{f ∗ f}(µA + µN − 2µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G2(−x)g6(x)
]
dx
∣∣∣
β=β0
= (ιC ι
2
A ιN + ιC ι
3
N)
(
{f ∗ f}(µN − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G2(−x)g7(x)
]
dx
∣∣∣
β=β0
= ιC ιA ι
2
N
(
2 · {f ∗ f}(µA − 2µN + µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G2(−x)g8(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G3(−x)g1(x)
]
dx
∣∣∣
β=β0
= ι3C ιN
(
{f ∗ f}(µN − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G3(−x)g2(x)
]
dx
∣∣∣
β=β0
= ι2C ι
2
N
(
{f ∗ f}(0)
)
,
−
∫ +∞
−∞
∂
∂β
[
G3(−x)g3(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G3(−x)g4(x)
]
dx
∣∣∣
β=β0
= ι2C ιA ιN
(
{f ∗ f}(µA + µN − 2µC)
)
,
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−
∫ +∞
−∞
∂
∂β
[
G3(−x)g5(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G3(−x)g6(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G3(−x)g7(x)
]
dx
∣∣∣
β=β0
= ιC ιA ι
2
N
(
{f ∗ f}(µA − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G3(−x)g8(x)
]
dx
∣∣∣
β=β0
= ιC ιA ι
2
N
(
− {f ∗ f}(µA − 2µN + µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G4(−x)g1(x)
]
dx
∣∣∣
β=β0
= ι3C ιA
(
2 · {f ∗ f}(µA − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G4(−x)g2(x)
]
dx
∣∣∣
β=β0
= ι2C ιA ιN
(
2 · {f ∗ f}(µA − µN)
)
,
−
∫ +∞
−∞
∂
∂β
[
G4(−x)g3(x)
]
dx,
∣∣∣
β=β0
= ι2C ιA ιN
(
{f ∗ f}(µA + µN − 2µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G4(−x)g4(x)
]
dx
∣∣∣
β=β0
= ι2C ι
2
A
(
2 · {f ∗ f}(2µA − 2µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G4(−x)g5(x)
]
dx
∣∣∣
β=β0
= ι2C ι
2
A
(
{f ∗ f}(0)
)
,
−
∫ +∞
−∞
∂
∂β
[
G4(−x)g6(x)
]
dx
∣∣∣
β=β0
= (ιC ι
3
A + ιC ιA ι
2
N)
(
{f ∗ f}(µA − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G4(−x)g7(x)
]
dx
∣∣∣
β=β0
= ιC ι
2
A ιN
(
2 · {f ∗ f}(2µA − µN − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G4(−x)g8(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G5(−x)g1(x)
]
dx
∣∣∣
β=β0
= ι3C ιA
(
{f ∗ f}(µA − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G5(−x)g2(x)
]
dx
∣∣∣
β=β0
= ι2C ιA ιN
(
{f ∗ f}(µA + µN − 2µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G5(−x)g3(x)
]
dx
∣∣∣
β=β0
= 0,
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−
∫ +∞
−∞
∂
∂β
[
G5(−x)g4(x)
]
dx
∣∣∣
β=β0
= ι2C ι
2
A
(
{f ∗ f}(0)
)
,
−
∫ +∞
−∞
∂
∂β
[
G5(−x)g5(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G5(−x)g6(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G5(−x)g7(x)
]
dx
∣∣∣
β=β0
= ιC ι
2
A ιN
(
{f ∗ f}(µN − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G5(−x)g8(x)
]
dx
∣∣∣
β=β0
= ιC ι
2
A ιN
(
− {f ∗ f}(2µA − µN − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G6(−x)g1(x)
]
dx
∣∣∣
β=β0
= (ι2C ι
2
A + ι
2
C ι
2
N)
(
{f ∗ f}(0)
)
,
−
∫ +∞
−∞
∂
∂β
[
G6(−x)g2(x)
]
dx
∣∣∣
β=β0
= (ιC ι
2
A ιN + ιC ι
3
N)
(
{f ∗ f}(µN − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G6(−x)g3(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G6(−x)g4(x)
]
dx
∣∣∣
β=β0
= (ιC ι
3
A + ιC ιA ι
2
N)
(
{f ∗ f}(µA − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G6(−x)g5(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G6(−x)g6(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G6(−x)g7(x)
]
dx
∣∣∣
β=β0
= (ι3A ιN + ιA ι
3
N)
(
{f ∗ f}(µA − µN)
)
,
−
∫ +∞
−∞
∂
∂β
[
G6(−x)g8(x)
]
dx
∣∣∣
β=β0
= (ι3A ιN + ιA ι
3
N)
(
− {f ∗ f}(µA − µN)
)
,
−
∫ +∞
−∞
∂
∂β
[
G7(−x)g1(x)
]
dx
∣∣∣
β=β0
= ι2C ιA ιN
(
2 · {f ∗ f}(µA − µN)
)
,
−
∫ +∞
−∞
∂
∂β
[
G7(−x)g2(x)
]
dx
∣∣∣
β=β0
= ιC ιA ι
2
N
(
2 · {f ∗ f}(µA − 2µN + µC
)
,
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−
∫ +∞
−∞
∂
∂β
[
G7(−x)g3(x)
]
dx
∣∣∣
β=β0
= ιC ιA ι
2
N
(
{f ∗ f}(µA − µC
)
,
−
∫ +∞
−∞
∂
∂β
[
G7(−x)g4(x)
]
dx
∣∣∣
β=β0
= ιC ι
2
A ιN
(
2 · {f ∗ f}(2µA − µN − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G7(−x)g5(x)
]
dx
∣∣∣
β=β0
= ιC ι
2
A ιN
(
{f ∗ f}(µN − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G7(−x)g6(x)
]
dx
∣∣∣
β=β0
= (ι3A ιN + ιA ι
3
N)
(
{f ∗ f}(µA − µN)
)
,
−
∫ +∞
−∞
∂
∂β
[
G7(−x)g7(x)
]
dx
∣∣∣
β=β0
= ι2A ι
2
N
(
2 · {f ∗ f}(2µA − 2µN)
)
,
−
∫ +∞
−∞
∂
∂β
[
G7(−x)g8(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G8(−x)g1(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G8(−x)g2(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G8(−x)g3(x)
]
dx
∣∣∣
β=β0
= ιC ιA ι
2
N
(
− {f ∗ f}(µA − 2µN + µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G8(−x)g4(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G8(−x)g5(x)
]
dx
∣∣∣
β=β0
= ιC ι
2
A ιN
(
− {f ∗ f}(2µA − µN − µC)
)
,
−
∫ +∞
−∞
∂
∂β
[
G8(−x)g6(x)
]
dx
∣∣∣
β=β0
= (ι3A ιN + ιA ι
3
N)
(
− {f ∗ f}(µA − µN)
)
,
−
∫ +∞
−∞
∂
∂β
[
G8(−x)g7(x)
]
dx
∣∣∣
β=β0
= 0,
−
∫ +∞
−∞
∂
∂β
[
G8(−x)g8(x)
]
dx
∣∣∣
β=β0
= ι2A ι
2
N
(
− 2 · {f ∗ f}(2µA − 2µN)
)
.
The desired result follows from summing up these 64 terms.
We then find the ARE between the two IVs for the sign test under the same setting.
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Let µ(β) = Pβ(X > 0) = 1−Gβ(0), then we have
µ(β) = 1− ι2C F (−β + β0)− ιC ιN F (µN − µC − β + β0)− ιC ιN F (−µN + µC)
− ιC ιA F (−µA + µC − β + β0)− ιC ιA F (µA − µC)− (ι2A + ι2N) F (0)
− ιA ιN F (−µA + µN − β + β0)− ιA ιN F (−µN + µA + β − β0).
Then we have
µ′(β0) = ι2C f(0) + ιC ιN f(µN − µC)
+ ιC ιA f(−µA + µC) + ιA ιN f(−µA + µN)− ιA ιN f(−µN + µA)
= ι2C f(0) + ιC ιN f(µN − µC) + ιC ιA f(−µA + µC).
By Example 3.3.5 in Lehmann (2004), the ARE under the sign test is the ratio of {µ′(β0)}2
under %1 and %2. So the desired result follows.
B.2: Proof of Theorem 1
When µA = µN = µC , by Theorem 5, we have
ψwilc(ιC , ιA, ιN , µC , µA, µN) = {f ∗ f}(0) · (2 · ι4C + 6 · ι3C ιA + 6 · ι2C ι2A + 2 · ιC ι3A
+ 6 · ι3C ιN + 6 · ι2C ι2N + 2 · ιC ι3N
+ 12 · ι2C ιA ιN + 6 · ιC ι2A ιN + 6 · ιC ιA ι2N)
= 2 · {f ∗ f}(0) · ιC · (ιC + ιA + ιN)3
= 2 · {f ∗ f}(0) · ιC .
Therefore, invoking Theorem 5, we have for the Wilcoxon signed rank test,
lim
n→∞
In,1
In,2
=
ψ2wilc(ιC,2, ιA,2, ιN,2, µC,2, µA,2, µN,2)
ψ2wilc(ιC,1, ιA,1, ιN,1, µC,1, µA,1, µN,1)
=
ι2C,2
ι2C,1
.
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Similarly, when µA = µN = µC , by Theorem 5, we have
ψsign = ι
2
C f(0) + ιC ιN f(µN − µC) + ιC ιA f(−µA + µC)
= ι2C f(0) + ιC ιN f(0) + ιC ιA f(0)
= ιC f(0).
Therefore, invoking Theorem 5, we have for the sign test,
lim
n→∞
In,1
In,2
=
ψ2sign(ιC,2, ιA,2, ιN,2, µC,2, µA,2, µN,2)
ψ2sign(ιC,1, ιA,1, ιN,1, µC,1, µA,1, µN,1)
=
ι2C,2
ι2C,1
.
B.3: Proof of Theorem 2
It suffices to show that if ξ(z˜,x, u) ∈ G, then (S2) implies that (S1) is not true, i.e.,
Z˜ |= U | X. Since ξ(z˜,x, u) ∈ G, there exists nonnegative functions η, ζ, and ϑ, such
that ξ(z˜,x, u) = η(x, u)ζ(z˜,x)ϑ(z˜, u), where ϑ is a smooth function over the support of ξ.
Without loss of generality, we assume that the support of ξ is Rp+2. Otherwise, we just
need to apply our argument over that support. To show that Z˜ |= U | X, since ξ ∈ G, it
suffices to show that ϑ(z˜, u) = ϑ1(z˜)ϑ2(u) for some functions ϑ1 and ϑ2. This is because if
f(Z˜ = z˜ | X = x, U = u) = ξ(z˜,x, u) = η(x, u)ζ(z˜,x)ϑ(z˜, u) = η(x, u)ζ(z˜,x)ϑ1(z˜)ϑ2(u),
we have f(Z˜ = z˜ | X = x, U = u) ∝ ζ(z˜,x)ϑ1(z˜), that is, Z˜ |= U | X. Therefore, it
suffices to show that if (S2) holds true, there exist two functions ϑ1 and ϑ2 such that
ϑ(z˜, u) = ϑ1(z˜)ϑ2(u). Assuming that Z˜i1 6= Z˜i2 in pair i, we have
P (Z˜i1 = Z˜i1 ∧ Z˜i2, Z˜i2 = Z˜i1 ∨ Z˜i2 | F ,Z, Z˜∨, Z˜∧)
=
ξ(Z˜i1 ∧ Z˜i2,xi1, ui1)ξ(Z˜i1 ∨ Z˜i2,xi2, ui2)
ξ(Z˜i1 ∧ Z˜i2,xi1, ui1)ξ(Z˜i1 ∨ Z˜i2,xi2, ui2) + ξ(Z˜i1 ∨ Z˜i2,xi1, ui1)ξ(Z˜i1 ∧ Z˜i2,xi2, ui2)
=
density odds ratio
density odds ratio + 1
,
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where we have
density odds ratio
=
ξ(Z˜i1 ∧ Z˜i2,xi1, ui1)ξ(Z˜i1 ∨ Z˜i2,xi2, ui2)
ξ(Z˜i1 ∨ Z˜i2,xi1, ui1)ξ(Z˜i1 ∧ Z˜i2,xi2, ui2)
=
η(xi1, ui1)ζ(Z˜i1 ∧ Z˜i2,xi1)ϑ(Z˜i1 ∧ Z˜i2, ui1)η(xi2, ui2)ζ(Z˜i1 ∨ Z˜i2,xi2)ϑ(Z˜i1 ∨ Z˜i2, ui2)
η(xi1, ui1)ζ(Z˜i1 ∨ Z˜i2,xi1)ϑ(Z˜i1 ∨ Z˜i2, ui1)η(xi2, ui2)ζ(Z˜i1 ∧ Z˜i2,xi2)ϑ(Z˜i1 ∧ Z˜i2, ui2)
=
ϑ(Z˜i1 ∧ Z˜i2, ui1)
ϑ(Z˜i1 ∧ Z˜i2, ui2)
· ϑ(Z˜i1 ∨ Z˜i2, ui2)
ϑ(Z˜i1 ∨ Z˜i2, ui1)
. (given xi1 = xi2)
If (S2) holds true, we have for all ui1 and ui2, the density odds ratio does not depend
on Z˜i1 ∧ Z˜i2 or Z˜i1 ∨ Z˜i2. Therefore, the function ϑ(z˜, ui1)/ϑ(z˜, ui2), or equivalently, the
function lnϑ(z˜, ui1)− lnϑ(z˜, ui2) does not depend on z˜, for all ui1 and ui2. Thus, we have
for all z˜, ui1, and ui2,
∂
∂z˜
( lnϑ(z˜, ui1)− lnϑ(z˜, ui2)
ui1 − ui2
)
≡ 0.
Therefore, for all z˜ and u, by smoothness of ϑ, we have
∂2 lnϑ(z˜, u)
∂z˜∂u
=
∂
∂z˜
(
lim
u′→u
lnϑ(z˜, u′)− lnϑ(z˜, u)
u′ − u
)
= lim
u′→u
∂
∂z˜
( lnϑ(z˜, u′)− lnϑ(z˜, u)
u′ − u
)
≡ 0.
Let h(z˜, u) = lnϑ(z˜, u), we then get for all z˜ and u,
∂2h(z˜, u)
∂z˜∂u
≡ 0. (19)
It is well known that if h(z˜, u) = lnϑ(z˜, u) is a smooth solution to the second order linear
partial differential equation (19), we have h(z˜, u) = ω1(z˜) + ω2(u) for some functions ω1
and ω2 (Strauss, 2007). Thus, let ϑ1(z˜) = exp(ω1(z˜)) and ϑ2(u) = exp(ω2(u)), we have
ϑ(z˜, u) = ϑ1(z˜)ϑ2(u). Therefore, the desired result follows.
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B.4: Proof of Theorem 3
Note that
1√
I
·
β̂IV − β −
∑I
i=1(Zi1−Zi2)[f(Xi1)−f(Xi2)]∑I
i=1(Zi1−Zi2)(Di1−Di2)
− δ ·
∑I
i=1(Zi1−Zi2)(Ui1−Ui2)∑I
i=1(Zi1−Zi2)(Di1−Di2)√
2σ∑I
i=1(Zi1−Zi2)(Di1−Di2)
=
1√
2σ
1√
I
I∑
i=1
(T i − Ci),
where T i = i1 · 1(Z˜i1 < Z˜i2) + i2 · 1(Z˜i1 > Z˜i2), and Ci = i1 · 1(Z˜i1 > Z˜i2) + i2 ·
1(Z˜i1 < Z˜i2). Note that since {n : n = 1, . . . , N} |= {(Z˜n,Xn, Un) : n = 1, . . . , N}, by
Definition 1, we have {n : n = 1, . . . , N} |= M. Thus, we have T1, . . . , TI , C1, . . . , CI
are i.i.d. with expectation E[] = 0 and variance σ2. Thus, T i − Ci, i = 1, . . . , N are
i.i.d. with expectation zero and variance 2σ2. By the central limit theorem, we have
1√
2σ
1√
I
∑I
i=1(T i − Ci) L−→ N (0, 1). So the desired result follows.
B.5: Proof of Theorem 4
Under the outcome generating model (6), β̂IV can be decomposed into:
β̂IV =
∑I
i=1(Zi1 − Zi2)(Ri1 −Ri2)∑I
i=1(Zi1 − Zi2)(Di1 −Di2)
=
∑I
i=1(Zi1 − Zi2)[(βDi1 + f(Xi1) + δUi1 + i1)− (βDi2 + f(Xi2) + δUi2 + i2)]∑I
i=1(Zi1 − Zi2)(Di1 −Di2)
= β +
∑I
i=1(Zi1 − Zi2)(f(Xi1)− f(Xi2))∑I
i=1(Zi1 − Zi2)(Di1 −Di2)
+ δ ·
∑I
i=1(Zi1 − Zi2)(Ui1 − Ui2)∑I
i=1(Zi1 − Zi2)(Di1 −Di2)
+
∑I
i=1(Zi1 − Zi2)(i1 − i2)∑I
i=1(Zi1 − Zi2)(Di1 −Di2)
. (20)
For the second term of (20), by Assumption 2, we have∑I
i=1(Zi1 − Zi2)(f(Xi1)− f(Xi2))∑I
i=1(Zi1 − Zi2)(Di1 −Di2)
=
1
I
∑I
i=1 f(XT i)− 1I
∑I
i=1 f(XCi)
1
I
∑I
i=1DT i − 1I
∑I
i=1 DCi
p−→ EM,T [f(X)]− EM,C [f(X)]
EM,T [D]− EM,C [D] .
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For the third term of (20), by Assumption 2, we have∑I
i=1(Zi1 − Zi2)(Ui1 − Ui2)∑I
i=1(Zi1 − Zi2)(Di1 −Di2)
=
1
I
∑I
i=1 UT i − 1I
∑I
i=1 UCi
1
I
∑I
i=1 DT i − 1I
∑I
i=1DCi
p−→ EM,T [U ]− EM,C [U ]
EM,T [D]− EM,C [D] .
For the last term of (20), as discussed in the proof of Theorem 3, by Definition 1, we have
T1, . . . , TI , C1, . . . , CI are i.i.d. with expectation zero and variance σ2. By Assumption 2,
we have∑I
i=1(Zi1 − Zi2)(i1 − i2)∑I
i=1(Zi1 − Zi2)(Di1 −Di2)
=
1
I
∑I
i=1 T i − 1I
∑I
i=1 Ci
1
I
∑I
i=1DT i − 1I
∑I
i=1 DCi
p−→ E[]− E[]
EM,T [D]− EM,C [D] = 0.
Putting all the above results together, we have
β̂IV − β =
∑I
i=1(Zi1 − Zi2)(f(Xi1)− f(Xi2))∑I
i=1(Zi1 − Zi2)(Di1 −Di2)
+ δ ·
∑I
i=1(Zi1 − Zi2)(Ui1 − Ui2)∑I
i=1(Zi1 − Zi2)(Di1 −Di2)
+
∑I
i=1(Zi1 − Zi2)(i1 − i2)∑I
i=1(Zi1 − Zi2)(Di1 −Di2)
p−→ EM,T [f(X)]− EM,C [f(X)]
EM,T [D]− EM,C [D] + δ ·
EM,T [U ]− EM,C [U ]
EM,T [D]− EM,C [D] .
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Supplementary Materials C: Additional Simulations
C.1: More simulations on Theorem 1
Figure 4: Panels (a), (b), and (c): power against sample size for three pairs of IVs with different
strength: β − β0 = 0.1, Laplace error, α = 0.05. Panel (d): sample sizes needed to obtain a
fixed power for the stronger and weaker IV in each pair. Lines with slopes equal to ι2C,2/ι
2
C,1 are
imposed.
(a) Pair 1: (ιC,1 = 0.5, ιC,2 = 0.6) (b) Pair 2: (ιC,1 = 0.4, ιC,2 = 0.7)
(c) Pair 3: (ιC,1 = 0.3, ιC,2 = 0.8) (d) Sample size ratio
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C.2: Simulated bias of β̂IV for two designs
Simulation 1 (Bias of β̂IV due to unmeasured confounding). Let R be the observed out-
come, D the binary treatment, Z˜ the continuous doses of encouragement, (X1, X2) two
observed covariates, and U an unmeasured confounder. {(Rn, Dn, Z˜n, X1n, X2n, Un), n =
1, . . . , 400} represents data before matching and are i.i.d random vectors from the follow-
ing data generating process:
Rn = β ·Dn + sin(X1n) +X32n + δ · Un + 1n,
Dn = 1{c1 · Z˜3n + c2 · Z˜n + 0.2 ·X1n + 0.4 ·X2n + 2n > c3},
Un = f(Z˜n) + 3n,
where Z˜n
i.i.d.∼ N (µ, σ2IV), X1n i.i.d.∼ N (0, 1), X2n i.i.d.∼ N (0, 1), 3n i.i.d.∼ N (0, 1) and
(1n, 2n)
i.i.d.∼ N
 0
0
 ,
 1 0.5
0.5 1
 .
Consider the following three specific models:
• Model 1: δ = 1, c1 = 0, c2 = 1, c3 = 0, f(z) = z, µ = 0, σ2IV = 1.
• Model 2: δ = 1, c1 = 1, c2 = 1, c3 = 4, f(z) = 1/(z − 1), µ = 1, σ2IV = 5.
• Model 3: δ = 10−6, c1 = 1, c2 = 1, c3 = 4, f(z) = exp(z), µ = 1, σ2IV = 5.
We consider two designsM0 andM1. M0 forms 200 pairs with similar (X1, X2) but
distinct Z˜ using optimal non-bipartite matching; M1 forms 100 matched pairs that are
still similar in (X1, X2) but more distinct in Z˜ by adding e = 200 “sinks” and a penalty
caliper Λ = 8. See Supplementary Materials A.1 for more details on matching.
In Table 6, we report the following three quantities averaging over 20,000 replications,
for both designsM =M0 andM =M1: 1) Estimated compliance rate: (1/I)
∑I
i=1(Zi1−
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Zi2)(Di1−Di2); 2) Absolute average encouraged-minus-control difference in U : |(1/I)
∑I
i=1(Zi1−
Zi2)(Ui1−Ui2)|; 3) Absolute bias contributed by U : δ·|
∑I
i=1(Zi1−Zi2)(Ui1−Ui2)/
∑I
i=1(Zi1−
Zi2)(Di1 − Di2)|. We also report the ratio of the magnitude of bias contributed by U for
two designs.
Table 6: Simulation results: strengthening an IV may amplify the bias
Model 1 Model 2 Model 3
M0 M1 M0 M1 M0 M1
Average compliance rate 0.32 0.37 0.50 0.89 0.50 0.89
Absolute difference in U 1.13 1.36 0.73 0.37 9.16× 105 4.54× 106
Absolute bias contributed by U 3.62 3.81 1.56 0.41 1.82 5.11
Ratio of bias ∆ 1.05 ≈ 1 0.26 < 1 2.81 > 1
Table 6 shows that the strengthening-IV designM1 may render the bias larger (∆ > 1),
almost the same (∆ ≈ 1), or smaller ∆ < 1, compared to M0. We see that M1 always
has a larger estimated compliance rate, as expected. Meanwhile, the absolute average
encouraged-minus-control difference in U also gets larger in all three data-generating pro-
cesses, because larger difference in Z˜ corresponds to larger difference in U according to the
data-generating process. Whether or not the magnitude of bias contributed by U would
increase or decrease depends on both the magnitude of change in the estimated compliance
rate and the magnitude of encouraged-minus-control difference in U .
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